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Abstract
Among the transmissible spongiform encephalopathies (TSEs), chronic wasting 
disease (CWD) in cervids is now the rising concern within Europe. CWD will be 
outlined in this chapter gathering its epidemiology, transmission, diagnosis, genet-
ics, and control. Prion diseases are fatal neurodegenerative diseases characterized 
by the accumulation of an abnormal isoform of the prion protein (PrPc), usually 
designated by PrPsc or prion. CWD is a prion disease of natural transmission affect-
ing cervids detected mainly in North America. The first European case was detected 
in Norway, in 2016, in a wild reindeer; until April 2018, a total of 23 cases were 
described. The definite diagnosis is postmortem, performed in target areas of the 
brain and lymph nodes. Samples are first screened using a rapid test and, if positive, 
confirmed by immunohistochemistry and Western immunoblotting. It is not pos-
sible to establish a culling plan based on the genotype, once affected animals appear 
with all genotypes. However, some polymorphisms seem to result in longer incuba-
tion periods or confer a reduced risk. The control is not easy in captive cervids and 
even more in the wildlife; some recommendations have been proposed in order to 
understand the danger and impact of CWD on animal and public health.
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1. Introduction
The study and monitoring of wildlife diseases are key points for establishing 
conservational policies for wild fauna.
Wildlife are often in double risk from disease due to the high number of infec-
tious diseases of wildlife origin that affects humans and (or) domestic animals and 
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also the opposite, humans and domestic animals’ diseases that could affect the wild-
life. Likewise, due to habitat changes, the introduction of pathogens from domestic 
animals as well as other actions with long-term adverse effects for the conservation 
of species needs to have supervising.
As in other diseases, some wildlife animal species could be at risk for transmis-
sible spongiform encephalopathies (TSEs), acting as a potential prion reservoir, 
threatening the livestock and public health.
TSEs are fatal neurodegenerative diseases characterized by the accumulation of 
an abnormal isoform, partially resistant to the enzymatic digestion, of the cellular 
prion protein (PrPc), usually designated by PrPsc or prion. Due to its conforma-
tional arrangement, it is very resistant to common inactivation procedures used on 
conventional infectious agents. As PrPc is host-encoded by the PRNP gene, poly-
morphisms in this gene can act upon the susceptibility or the resistance to TSEs.
The most common and well-known diseases of this group are scrapie in small 
ruminants, bovine spongiform encephalopathy (BSE), Creutzfeldt-Jakob disease 
(CJD) in humans, and chronic wasting disease (CWD) in cervids.
Scrapie and CWD are recognized as natural transmitted TSEs, so wildlife can be 
naturally affected by these two TSEs.
Since scrapie was identified in mouflon sheep (Ovis musimon) [1], wild spe-
cies of sheep and goats, like Iberian wild goat (Capra pyrenaica), and Pyrenean 
chamois (Rupicapra P. pyrenaica) can also be infected by scrapie as well as by 
BSE. Furthermore, according to some studies, European wild ruminants have a 
PRNP genetic background that is compatible with TSE susceptibility [2, 3].
Albeit limited, some countries, namely, Estonia, Finland, Spain, and Cyprus, 
reported negative results on samples tested for TSE in other wild animal species—
mink (Mustela lutreola), fox (genus Vulpes), raccoon dog (Nyctereutes procyonoides), 
bison (Bison bison), and Cyprus mouflon (Ovis gmelini ophion) [4].
Considering that CWD is a TSE affecting several cervid species, a very conta-
gious disease with an efficient horizontal transmission, appearing to be enzootic 
and to be expanding both geographically and in prevalence [5], all the sections in 
this chapter are focused in order to better characterize the epidemiology, transmis-
sion, pathogenesis, diagnosis, genetics, and control of this disease.
2. Molecular basis of transmissible spongiform encephalopathies (TSEs)
2.1 Biology of the etiologic agent
Initially, TSEs were thought to be caused by “slow viruses” (reviewed in [6]). 
However, as the agent causing scrapie was not deactivated by both chemical and 
physical procedures, which modify or destroy nucleic acids, it was suggested that 
this infectious agent was not harboring nucleic acids. Thus, in 1967 Griffith pro-
posed a model in which the scrapie agent could be a protein, but it was Prusiner 
in 1982, after confirming that procedures used to modify or destroy proteins 
deactivated the scrapie agent, who published that the etiologic agents of TSEs were 
proteinaceous infectious particles, called prions [6, 7].
According to this protein-only hypothesis, TSEs are caused by the conversion 
of the physiological cellular prion protein (PrPc) into a pathogenic misfolded 
isoform (designated PrPsc) that is able to propagate by recruiting and transform-
ing more PrPc, by an increase in β-sheet structure and a propensity to aggregate 
into oligomers (reviewed [6, 8]). Moreover, this conformational change confers 
to PrPsc a greater insolubility in nonionic detergents, high resistance to heat and 
chemical sterilization, and partial resistance to protease digestion—the truncated 
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PrP 27–30 kDa (reviewed in [8–10]). Until now, this latter feature has been used for 
diagnostic purposes, being PrPsc a diagnostic marker for these diseases (see Section 
6 Diagnosis of CWD, in this chapter).
PrPc is host-encoded by the PRNP gene (see Section 2.3. Prion protein gene, 
in this chapter) and is normally present in the cell surface in different organs 
and tissues of mammals and other vertebrates but with high expression levels in 
the central and peripheral nervous systems. It is a glycosylphosphatidylinositol 
(GPI)-anchored glycoprotein of 33–35 kDa with a C-terminal globular domain, 
an N-terminal flexible tail, a single disulfide bond, and an α-helix content. 
The N-terminal tail includes two charged clusters, the octarepeat region and a 
hydrophobic domain. At the C-terminus, in the globular domain upstream of the 
sialylated GPI anchor, there are two N-glycosylation sites [11]. Thus, PrPc has two 
putative sites of glycosylation, and three glycoforms of PrP can be described: di-, 
mono-, and non-glycosilated PrP. The relative proportions of these glycoforms and 
the size of the unglycosylated PrPsc fragment are dependent on the strain of prion 
(reviewed in [12]).
Regarding the physiological function of the PrPc, it has not been clarified yet; 
nevertheless, there are several proposed roles; ones are supported by compatible 
results of different experiments (neuronal excitability; glutamate receptor func-
tion, neurite outgrowth; neuroprotection; copper, zinc, iron, and lactate metabo-
lism; and peripheral myelin maintenance), while others are yielding inconsistent 
results (synaptic transmission and plasticity, memory formation, stabilization of 
sleep and circadian rhythm, calcium homeostasis, and toxicity elicited by oligo-
meric species) [11].
While the structure of PrPc is well studied and identified, the structure of PrPsc, 
the mechanism by which PrPc converts into PrPsc in a posttranslational process, and 
the molecular mechanisms behind prion strains are still not known, despite all the 
experimental attempts [8–10].
PrPsc, as a physical template, compels PrPc, with the same primary but different 
secondary, tertiary, and quaternary structures, to adopt the PrPsc conformation, 
probably on a complete unfolding of PrPc, followed by refolding. To thoroughly 
comprehend this molecular process, it is essential to know the architecture of PrPsc. 
As extensively reviewed by Requena and Wille [9, 10], distinct molecular models 
have been proposed for PrPsc (27–30 kDa): (1) a four-stranded β-sheet plus two 
C-terminal α-helices [13, 14]; (2) an antiparallel, intertwined β-helix structure 
[15]; (3) a parallel β-helix [16]; (4) a fold modeled on the human TATA-box-binding 
protein containing a five-stranded β-sheet, with the C-terminal α-helices [17];  
(5) a “spiral model” with three α-helices of the original structure and four β-strands 
[18]; (6) a unit consisting of a left-handed four-rung parallel β-helical fold for 
the N-terminal part and α-helical state for the C-terminal portion, assembled as a 
trimer [19]; (7) a PrP primary structure based onto the β-helical template and the 
C-terminal α-helices [20]; (8) a β-helical architecture with a threefold domain in the 
trimeric unit and α-helical structure for the C-terminal portion [21]; (9) a two-rung 
β-helix with the C-terminal α-helices [22]; (10) a parallel in-register intermolecular 
β-sheet (PIRIBS) architecture [23, 24]; and (11) a parallel β-helix extended to the 
C-terminal portion of the PrP molecule [25].
Nevertheless, none of these models have explained all the experimental results. 
Recently, methodologies like cryo-electron microscopy and X-ray fiber diffraction 
have pointed out a four-rung β-solenoid as the basic structural element structure of 
PrPsc [26], though the available structural information is still limited to determine 
the PrPsc architecture in atomic details (reviewed in [10]).
To explain strain diversity of prions, the prion-only hypothesis considers that, 
in the absence of a nucleic acid, the variety of PrPsc conformers and its mixture 
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may result in different prion strains. Each prion strain presents a specific disease 
phenotype (incubation times, clinical signs, histopathological lesions, PrPsc deposi-
tion patterns in the brain, and PrPsc biochemical characteristics) which is exactly 
preserved upon serial passage within the same host genotype. Nevertheless, the 
molecular mechanisms by which a range of PrPsc conformers would be produced 
and selected have not been yet established (reviewed in [8]).
In relation to chronic wasting disease (CWD) prion strains, two prevalent CWD 
prion strains (CWD1 and CWD2) were identified in North America based on 
transmission in transgenic cervid (TgCerPrP) mice of several CWD isolates from 
different cervid species and geographic areas. CWD1 and CWD2 showed distinct 
incubation time, clinical signs, and neuropathologic profile but with indistinguish-
able electrophoretic migration patterns of di-, mono-, and non-glycosyl forms of 
PrPsc [27], reviewed in [28]. These bioassay results showed that elk may be infected 
with either CWD1 or CWD2 strains, while in deer CWD1/CWD2 strain mixture 
can be present ([27], reviewed in [28]) (Figure 1).
Regarding the CWD prion strain(s) responsible for the outbreaks of the disease 
in new geographic areas—South Korea, Norway, and Finland—the available data is 
still limited. The strain characterization of the Korean CWD cases in elk in 2001 and 
2004 suggested a single strain responsible for the outbreaks imported from Canada 
[29], without identifying if it was CWD1, CWD2, or both. The biochemical analysis 
and immunohistochemistry (IHC) distribution of PrPsc from Norway reindeer 
revealed a pattern indistinguishable from North America isolates [30]. Remarkably, 
in CWD-affected moose in Norway, a different phenotype was observed in both 
PrPsc distribution and biochemical features, suggesting a presence of a different 
type of CWD prion strain in moose from this country (designated Nor-16CWD) 
[31] (Figure 1).
Novel cervid prion strains have been experimentally generated by adaptation 
of prions from other species, for instance, scrapie (SSBP1, an American classical 
scrapie isolate) [28] and BSE [32], demonstrating that cervid species can also be 
susceptible to other prions. Moreover, CWD prions easily adapt to new species (see 
Section 4), including sheep, cattle, and squirrel monkeys. Thus, there is a putative 
risk of development of novel CWD-related prion disease in livestock by grazing in 
CWD-contaminated pasture (Figure 1). Lastly, the ability of the CWD prions to 
cross the human species barrier has to be further evaluated, but amino acid residues 
(residues 165–175) in the β2–α2 loop sequence of human PrPc can constitute a spe-
cies barrier to its conversion by CWD prions [33], reviewed in [28].
2.2 Prions and the deviations in the central dogma of molecular biology
According to the central dogma of molecular biology, first published in 1958 
and revisited later [34], heritable information is stored in DNA, expressed as RNA, 
and translated into protein. Nevertheless, this paradigm has been updated by many 
aspects of the regulation of gene expression, namely, by the identification and char-
acterization of alternative splicing, alternative promoters, alternative polyadenyl-
ation events, and the increasing number of noncoding RNAs (ncRNAs) with critical 
importance in the regulation of messenger RNA (mRNA) [35] and the discovery of 
“prions”: prion proteins can adopt multiple conformations, at least one of which has 
the capacity to self-template [36, 37] (Figure 2).
2.3 Prion protein gene (PRNP)
The astounding improvement in genetic tools and bioinformatic programs/
algorithms and the incredible amount of data deposited freely in the main scientific 
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databases allow us to use comparative genomics in an effective manner. Figure 3  
contains the representation of the PRNP gene in Homo sapiens, used as a refer-
ence and establishing a comparison with other animal species according to the 
Ensembl database. This gene is constituted by two exons, although a single exon 
is responsible for the open reading frame (ORF) and the remaining sequence 
contains untranslated and regulatory regions. Some animal species have the same 
distribution, while others contain a single exon (e.g., Canis lupus familiaris, Felis 
catus, and Ovis aries), three exons (Cervus elaphus and Odocoileus virginianus from 
Cervidae family), or four exons (like Bos taurus), according to Ensembl database. 
Nevertheless, a high level of conservation at the coding sequence and correspond-
ing protein sequence is maintained (as confirmed in Figure 4).
The fundamental event in the pathogenesis of TSE is not a primary structure 
modification but the conversion of the normal cellular prion protein (PrPc) into 
the misfolded pathogenic isoform (PrPsc) [38]. In fact, PrPc and PrPsc share the 
same amino acid sequence, but differences in the secondary structure originate the 
tertiary and quaternary structures that dictate the PrPsc with new physicochemical 
properties, namely, insolubility in nondenaturing detergents and partial resistance 
to proteolysis. It is therefore important to identify the specific codons and amino 
acids with relevant importance in the protein structure dynamics.
Rongyan and collaborators [39] compared the PRNP gene sequences among 83 
species and reinforced a remarkable degree of conservation among the mammalian 
sequences. In order to confirm this statement, a DNA, RNA, and protein compari-
son of PRNP among humans, bovine, ovine, caprine, and deer was performed. 
According to this comparison, human PRNP is less similar compared to the oth-
ers, which is understandable since they are phylogenetically more distant species. 
However, the protein comparison showed a high similarity between all these species 
(above 90%), indicating a high conservation of PrP.
In order to add supplementary information especially regarding wild species, the 
PrP protein sequences from 13 different species were compared and are presented in 
Figure 1. 
Summary of CWD prions and transmission. Like North America-CWD-isolates with PrPres biochemical and 
PrPres distribution similar to that described in North America CWD cases.  natural transmission;  
putative transmission;  experimental transmission;  potential spread of CWD prions or decrease of PrPres 
environmental reservoir at the carcass site due to scavenging process, (silhouettes and pictures from freepik.com 
and img.linkfrog.com).
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Figure 4. The high level of conservation suggests the preservation of some impor-
tant functional characteristics of PrP through evolution.
According to NCBI-SNP database (accessed in December 2018), 3683 variations 
in the human PRNP gene were presented. Some of these variations are located in 
the coding sequence and originate modifications in the protein. Once PrP is highly 
conserved, the variations already described in humans can be used to predict varia-
tions in other species. In order to simplify this process, all the missense and non-
sense mutations associated with prion diseases described in humans are presented in 
Figure 2.
Variations in PrP sequences exist between species and also between individu-
als of the same species. It was already demonstrated that this fact can influence 
the susceptibility to prion infection and ultimately to disease. Chronic wasting 
disease appear to have a higher potential of transmissibility than other forms 
of prion disease, and it has been confirmed that some genetic variations are 
associated with lower rates of infection and slower progression of clinical mani-
festations [40]. A total of 17 polymorphic sites have been reported in the PrP in 
Cervidae species.
Historically, O’Rourke and collaborators [41] were the first authors that 
reported that PRNP gene from Cervus elaphus was polymorphic at codon 132 
encoding methionine (M) or leucine (L). This codon is equivalent to codon 129 in 
Figure 2. 
Updated vision of the classical central dogma of the molecular biology. A DNA sequence can originate multiple 
RNAs (by using different promoters, by alternative polyadenylation and alternative splicing events). Some 
of these RNAs can be degraded by nonsense mediated decay (NMD), normally if they contain a premature 
termination codon (PTC). Other RNAs are not translated but still have a possible regulatory function 
(noncoding RNAs, ncRNA) and supplementary RNAs are translated originating a different protein, with similar 
or unrelated function comparing to the canonical protein. The prion postulation assumes that an abnormal 
protein conformation (PrPsc) propagates itself via an autocatalytic mode by recruiting the normal cellular 
isoform (PrPc) as a substrate and acting as the disease transmissible agent. This misfolding can be reversible and 
prion proteins have the ability to interact with nucleic acids (DNA and RNA) and other polyanions (as lipids).
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Figure 3. 
Organization of the Homo sapiens PRNP gene. From the two exons, only exon 2 is codifying for the PrP protein 
(black square). The coding sequence is presented below with the top lines showing the nucleotide sequence and 
the bottom lines showing the amino acid sequence. Missense and nonsense mutations in PrP associated with 
human prion diseases are marked in red. Information retrieved from Ensembl and NCBI databases were used 
to create this scheme.
the human protein encoding either M or valine (V) [42]. According to Collinge 
and colleagues [43] and Palmer and collaborators [44], this variation has an 
important impact on human prion disease presentation. In the same direction, 
regarding CWD, O’Rourke and collaborators [45, 46] indicated that the L132 
allele protected against this disease in Cervidae. Although all PRNP genotypes 
can be affected with CWD, there are some polymorphisms that appear to result in 
longer incubation periods in some species. The polymorphisms Q95H and G96S 
are related to the reduction of the risk of infection [47]. S96S or G96S and G95H 
Wildlife Population Monitoring
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seem to produce a reduced susceptibility, with longer survivor period [48], being 
underrepresented in CWD-affected populations [45]. Regarding S225F poly-
morphism there is a differential susceptibility to experimental oral exposure and 
incubation periods [45, 49].
Table 1 presents the information concerning the amino acidic variations 
reported until 2018, with the references and functional implications in the suscepti-
bility to CWD.
3. Epidemiology of chronic wasting disease (CWD)
3.1 Natural history and geographical distribution of CWD
Descriptions of CWD date back to 1967, in which a body-wasting syndrome 
associated with behavioral changes was described in Colorado in a closed herd 
of captive mule deer. However, only a few years later, in 1980, the patholo-
gists Elizabeth Williams and Stewart Young observed histological lesions that 
made it possible to identify the disease as transmissible spongiform encepha-
lopathy, in deer from wildlife research facilities in Colorado and Wyoming. 
These lesions included neuropil spongiform transformation, intracytoplasmic 
vacuoles in neuronal perikaryons, and significant astrocytic hyperplasia and 
hypertrophy [60].
Figure 4. 
Alignment of PrP protein sequences among 13 different species. T-coffee was the multiple alignment tool 
used from EMBL-EBI (https://www.ebi.ac.uk/Tools/msa/tcoffee/) and Genedoc version 2.7.000 was 
the multiple sequence alignment editor. The accession numbers of each species considering a short name 
(by order of presentation in the alignment) are: Hs_ENSP00000368752.4; Bt_ENSBTAP00000043233.2; 
Oa_ENSOARP00000004991.1; Ch_ NP_001301176; Rr_UniProt_spQ5XVM4; Cc_AY639096; Ce_UniProt_
spP67987; Cn_UniProt_trQ6DN38; Ov_UniProt_trQ7JIQ1; Oh_UniProt_trQ6VS46; Aa_UniProt_trQ693S2; 
Rtg_UniProt_trQ3Y673; Dd_UniProt_trQ7YSF3. Besides human (the reference), the four following species 
belong to Bovidae family and the last eight species belong to Cervidae family (highlighted with a rectangle 
frame). The arrows locate the seventeen polymorphic amino acids described in Cervidae.
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In 1991, amyloid plaques reactive to antibodies produced against scrapie were 
identified in the cerebral gray and white matter and in molecular, pyramidal, and 
granular layers of the cerebellum of infected captive mule deer (Odocoileus hemionus 
hemionus) [61]. In the same year, a similar study identified scrapie amyloid-immu-
noreactive plaques in Rocky Mountain elk (Cervus elaphus nelsoni) and hybrids of 
mule deer and white-tailed deer (WTD) (Odocoileus virginianus) [62].
After its first identification, CWD was detected in a mule deer from Wyoming, 
and, until 1980, they had already identified 53 cases in mule deer (Odocoileus hemio-
nus hemionus) and 1 case in a black-tailed deer (Odocoileus hemionus columbianus) 
from wildlife facilities in Colorado and Wyoming [60].
The disease continued to be detected in new cervid species as Rocky Mountain elk 
(Cervus elaphus nelsoni) in Colorado and Wyoming wildlife facilities [63]. Subsequently, 
the disease was identified in free-ranging animals: mule deer and elk in the same states 
[64] and white-tailed deer in Nebraska and South Dakota in 2001 [65, 66].
The limited area of southern Wyoming, Northern Colorado, and Western 
Nebraska has been considered the endemic area. This area spreads rapidly, and new 
epidemic outbreaks were identified in other states including areas not contiguous 
geographically to endemic areas [66].
The establishment of disease surveillance and detection programs in both wild 
and captive cervids contributes to the knowledge of the geographical distribution of 
the disease [67]. However, the lack of well-defined limits of the affected areas, the 
low incidence, and the insufficient sampling could lead to underestimated preva-
lence rates [66].
a.a Position Consensus a.a Variation Reference
2 V M [50]
20 D G [51, 52]
59 G S [3, 52]
95 Q H [40, 52, 53]
96 G S [52, 53]
98 T A [3]
100 S N [54]
116 A G [52]
129 G S [55]
132 M L [45, 56, 57]
138 S N [55]
168 P S [3]
169 V M [55]
209 M I [50]
225 S F [58]
226 Q E/K [3, 52, 58, 59]
230 Q L [52]
The position considers the Cervidae prion protein. Legend: amino acid codes—A, alanine; D, aspartic acid; E, glutamic 
acid; F, phenylalanine; G, glycine; H, histidine; I, isoleucine; K, lysine; L, leucine; M, methionine; N, asparagine; P, 
proline; Q , glutamine; R, arginine; S, serine; T, threonine; V, valine.
Table 1. 
Amino acid variations and susceptibility to CWD.
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At present, the disease has been identified in captive and free-ranging cervids in 
24 states of the United States of America (USA) [68]. Considering only free-ranging 
cervids, CWD was identified in 270 counties in 24 states, according to March 2019 
data, namely, Arkansas, Colorado, Illinois, Iowa, Kansas, Maryland, Michigan, 
Minnesota, Mississippi, Missouri, Montana, Nebraska, New Mexico, New York, 
North Dakota, Pennsylvania, South Dakota, Tennessee, Texas, Utah, Virginia, West 
Virginia, Wisconsin, and Wyoming [69, 70].
In Canada, the first case was detected in 1996 in Saskatchewan, in a captive 
elk [71]. The second case was diagnosed in 1998 in a farmed elk and the third 
case, in 2001, in a captive 24-month-old Rocky Mountain elk. In this herd, no 
other cases had been detected; however, an animal which died 2 years earlier 
without postmorten examination had been introduced previously from an 
infected herd [72]. In 2002, the first case was identified in farmed white-tailed 
deer [71]. Nevertheless, considering a retrospective study done in Toronto 
Zoo cervids that died between 1973 and 2003, CWD exists in Canada since the 
1980s. CWD infection was detected in seven mule deer and one black-tailed 
deer [73].
According to the Canadian Food Inspection Agency, data about cervid herds 
infected with CWD are reported since 1996 [69]. In 2001, CWD was identified in 
21 herds, the highest number between 1996 and 2018. Until last year, the disease 
was circumscribed to two provinces: Alberta and Saskatchewan [72]. A screening 
for CWD in caribou (Rangifer tarandus) in northern Quebec revealed no positive 
animals [74]. However, data from 2018 reported the disease in Quebec in a red deer 
herd [69, 70, 75].
Recent data, from 2018 official reports, describe CWD in captive elks (in the 
province of Alberta and Saskatchewan), white-tailed deer (in Saskatchewan), 
and red deer (in Quebec and Saskatchewan) [69, 75]. CWD was also identified in 
free-ranging cervid populations in Canadian Alberta and Saskatchewan provinces 
[69, 71, 75].
The first case outside North America was detected in 2002, in South Korea, 
associated with a 7-year-old elk imported from Canada [76].
CWD was first recognized in Europe in March 2016 in a free-ranging female 
reindeer (Rangifer tarandus) in the Nordfjella mountain range of Southern Norway 
[30]. Since then, Norway further intensified its monitoring by sampling with the 
aid of hunters and governmental culling. A total of 41,125 cervids had been tested 
leading to the detection of CWD in 19 wild reindeers (Rangifer tarandus), 3 wild 
moose (Alces alces alces), and 1 red deer (Cervus elaphus) [77, 78]. In Finland, one 
CWD-affected moose was detected in 2500 cervids tested [78].
3.2 Host range of CWD
CWD has been identified in several members of the family Cervidae: white-
tailed deer (Odocoileus virginianus) [79], mule deer (Odocoileus hemionus) [60], 
Rocky Mountain elk (Cervus elaphus nelsoni) [80], moose (Alces alces shirasi) [81], 
reindeer (Rangifer tarandus) [30], moose or Eurasian/European elk (Alces alces 
alces), and red deer (Cervus elaphus) [77].
There are other animals that can experimentally be infected, both cervid and 
noncervid species. The experimental host range includes squirrel monkey [82, 83], 
several species of voles [84, 85], white-footed mice [29], Syrian golden hamsters 
[86], ferrets [87], raccoons [88], cats [89], pigs [90], and sheep [91]. Other cervids 
are susceptible to experimental CWD infection: fallow deer (Dama dama) [92] and 
muntjac deer (Muntiacus reevesi) [93]. However, CWD was not yet detected natu-
rally in these species.
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3.3 Prevalence and dissemination of CWD
The prevalence of the CWD is quite different in wild or captive cervids. In 
free-ranging cervids, the disease spreads slowly, often with a stable prevalence and 
low diffusion rate [94]. However, CWD prevalence in wild cervids and geographi-
cal areas with animals infected are increasing every year. Prevalence could reach 
31% in hunting deer from Wyoming (USA) [95] and exceed 10% in elk from Rocky 
Mountain National Park [96]. In Europe, the prevalence in cervids in Norway is 
0.05% (23 in 41,125 cervids) and 0.04% in Finland (1 in 2500 cervids), which 
is very low, but it is expected to increase, as it is a very contagious form of TSE, 
endemic, and difficult to eradicate [78].
In captive cervids the prevalence is higher and may reach 79% or more of 
affected animals on the herd. In young animals, this number could be even higher 
[66, 97]. The annual incidence may be higher than 50% in white-tailed deer and 
mule deer [95].
The diffusion of CWD, despite the many studies existent, is not well under-
stood. The disease spreads slowly, in free-ranging cervids, probably following river 
corridors or associated with the movements of males, as proposed for white-tailed 
deer (Odocoileus virginianus) [98]. However, there are no definite conclusions 
about the origin of the disease in wild cervids. CWD foci in these animals could be 
extensions of the initial endemic focus, secondary foci, or they could correspond 
to the spontaneous development of different foci of the disease [94]. In captive 
animals, CWD spread probably followed slightly different pathways. The occur-
rence of the disease and its irregular propagation with their appearance in two 
geographically distant endemic regions must be associated with the commercial-
ization of infected animals between the different herds. Occasionally the disease 
was detected simultaneously in herds and wild animals in the same region, previ-
ously or later, in wild animals suggesting a spillover of the infection from captive 
to free-ranging animals [94].
4. Transmission
Concerns about transmission between species of TSEs, and particularly trans-
mission of animal TSEs to humans, have existed since the infectious nature of these 
diseases was demonstrated, but there was no evidence of zoonotic transmission 
until the link between BSE and a new human TSE (variant CJD or vCJD) was estab-
lished in the late 1990s. Evidence for the transmission of BSE from cattle to humans 
came from a diversity of sources, combining careful surveillance and epidemiologi-
cal studies, often involving the development of new techniques and animal models. 
The demonstration of the zoonotic transmission of BSE also renewed concerns 
about the public health risks of other TSEs leading to enhanced surveillance and 
efforts to control scrapie and CWD [99].
Efficient control measures were applied for BSE and scrapie in cattle, sheep, and 
goats. However, CWD prions present a challenging risk, affecting both captive and 
wild cervids [100].
The experimental transmission of BSE in cervids and the bioassay in trans-
genic mice strongly support the claim that CWD agents are not related to classical 
BSE. However, the possible relationships between CWD and other TSE agents 
circulating in animal populations (transmissible mink encephalopathy (TME), 
scrapie) are still uncertain [99].
TSEs are horizontally transmitted by oral ingestion (kuru, BSE, vCJD, TME, 
feline spongiform encephalopathy (FSE), CWD), by environmental contact with 
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infectious prions (scrapie, CWD), by blood transfusion (vCJD, CWD, scrapie), or 
by iatrogenic exposure (vCJD, sCJD) [93]. Horizontal transmission of CWD also 
includes skin, oral, and nasal routes [101].
CWD prions can be discarded in urine, feces, saliva, blood, and velvet antler 
(clinical and preclinical stage of the infection) and can be found in skeletal muscle, 
fat, viscera, and the central nervous system [102, 103]. For this, there is a high risk 
of exposure to CWD prions, not only for cervids and other wild animals but also 
for hunters who may contact directly with infected animals and people consuming 
venison [104] (Figure 1).
Although still unclear, natural CWD transmission between animals has 
occurred. Environmental contamination and infectivity can persist in pastures for 
2 years after the death of animals affected with CWD, as shown by studies per-
formed in grazing presumably highly contaminated [49].
Both horizontal and environmental transmissions efficiently disseminate 
CWD. Decomposing carcasses and the placenta also contribute for this transmis-
sion as the prion agent is environmentally very stable persisting for many years 
where TSE-infected animals stood [94]. Other putative sources for CWD spread 
are predators/raptors and scavengers as prions remained infectious after passage 
through the digestive system of American crows [105, 106] and coyotes [107] which 
were orally infected with scrapie and CWD, respectively (Figure 1).
High infectivity and rapid transmission between cervids result in a high preva-
lence and can exceed 90% in captive animals [108] leading to the increased CWD 
exposure of humans and other animals, mainly by the consumption of prion-
infected animal products or grazing on prion-contaminated pastures, respectively. 
So, studies concerning the zoonotic risk of CWD and transmission to other animal 
species are very important with a high interest for public and animal health. The 
effect of the species barrier (lower transmission efficiency compared to that within 
the donor species) is very present while studying the interspecies transmission of 
CWD prions. Investigations identified a key influence of amino acid sequence dif-
ferences in the prion protein between species as well as a strong effect of the prion 
strain type [109, 110]. For prions, strain type is characterized by a set of properties 
that define infection and pathogenesis not explained by differences in amino acid 
sequence [111]. Both factors influence species interaction, dose, route of inocula-
tion, and age of the host [109, 110]. Furthermore, prion agents can adapt to a new 
host species, only becoming virulent after repeated passage [112].
For the study of CWD interspecies transmission, experimental inoculations 
were conducted mainly by intracerebral (IC) inoculation, resulting in a success-
ful transmission to ferrets (Mustela putorius furo) [113] but unsuccessful to Syrian 
golden hamsters (Mesocricetus auratus) even after multiple attempts [64]. The 
ferret-adapted CWD was, however, and after several passages, transmitted to ham-
sters, demonstrating that interspecies transmission can be altered by the adaptation 
to a new host [113]. The IC inoculation of mule deer CWD to goats presented an 
incubation period of about 6 years, a longer period when compared to what hap-
pens with scrapie [64, 114].
Transmission experiments of CWD prions from white-tailed deer, mule deer, 
and elk to transgenic mice expressing deer, elk, sheep, cattle, or human PrPc sug-
gest that the transmission barrier for CWD prions among different species of the 
cervid family is low, whereas the transmission barrier for CWD prions to sheep, 
cattle, and humans is high ([115–119], cited by [114]). Although still unclear, 
species barrier is thought to be controlled, at least in part, by the differences in 
the primary PrP sequences of donor and recipient animals [120–122] that affect 
the structure and folding of each prion protein ([123] cited by [114]). Studies of 
amino acid differences have demonstrated that there is a high level of conservation 
13
TSE Monitoring in Wildlife Epidemiology, Transmission, Diagnosis, Genetics and Control
DOI: http://dx.doi.org/10.5772/intechopen.85797
of the prion protein between species (90%) being the energy barrier increased for 
conversion, when compared to others, with some major differences in the amino 
acid sequence [33].
Although the hypothesis that CWD is transmitted to humans is not supported 
(reviewed by [100]), results from in vitro experiments suggest that the species 
barrier is not absolute.
No correlation between CWD prion exposure and human prion disease was 
demonstrated by epidemiological studies, and humanized transgenic mice did not 
demonstrate transmission. CWD transmission to macaques has been unsuccessful 
to date, although squirrel monkeys seem to be susceptible to CWD prions [100].
The negative transmission results reported in seven studies support the conclu-
sion that the transmission barrier associated with the interaction of human PrP and 
CWD prions is fairly strong and is stronger than the species barrier between human 
PrP and the BSE prion ([124] cited by [100]).
It is hypothesized that, as a result of an extensive human exposure, a CWD prion 
strain able to be transmitted to humans can emerge, even with no current evidence 
that it can cause disease [125]. So there is a risk of exposure for those who directly 
contact with cervids or contaminated environment or who consume venison [104]. 
However, variation in CWD prion strains, human genetic heterogeneity, other fac-
tors contributing to individual variation, and some evidence that intraspecies and 
interspecies passage of CWD prions may increase the risk that CWD prions adapt 
to have a lower species barrier for transmission to humans, complicating this area of 
research [112].
Wild-type inbred strains of mice (e.g., RIII, C57BL, and VM) were important 
for the identification and characterization of different types of scrapie prions 
[126–131], but CWD transmission to wild-type mice presented only few results 
[29]. In order to optimize time and resources as well as the results obtained, when 
performing studies of scrapie prions, transgenic (Tg) mice for ovine or cervid prion 
protein gene were developed [115, 117, 118, 132–134].
According to several studies, cervidized mice have been established as appropri-
ate mouse bioassay models for the study of CWD. CWD prions were transmitted 
efficiently to TgElk mice with no evidence of transmission to ovinized mice—Tg338 
(transgenic mouse line expressing the ovine VRQ prion protein) [119].
There are currently no known cases of interspecies transmission of CWD prions 
to sheep or goats through natural exposure, and transmission resulting from direct 
inoculation has been relatively inefficient. Nevertheless, the potential for natural 
exposure of sheep and goats to CWD prions is presumably rising in parallel with 
the increasing incidence and geographic range of CWD [119]. In this study trans-
mission of classical scrapie and CWD prions from their native hosts to transgenic 
mouse lines expressing the ovine (Tg338) or cervid PrP was assessed. Inoculation 
of transgenic mice with scrapie prions from small ruminants or CWD prions from 
WTD (white-tailed deer) resulted in distinct transmission patterns. Scrapie prions 
transmitted efficiently to Tg338 but not to TgElk, whereas CWD prions from a 
natural host efficiently transmitted to TgElk but not Tg338. Unlike these distinct 
transmission patterns, efficient transmission of CWD prions following primary 
passage in sheep was observed in both Tg338 and TgElk mice. Experimentally 
transmitted CWD in small ruminants has been difficult to distinguish from natural 
cases of classical scrapie [119].
Peripheral lymphoid tissues may be a target for accumulation in cross-species 
transmission as observed with Tg338 mice intracerebrally inoculated with elk CWD 
prions with high rates in the spleen but low doses in the brain [110]. Transmission 
of CWD from mule deer or elk to sheep has been achieved following intracerebral 
inoculation [91, 135]. Yet, inoculation with brain homogenate from WTD with 
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CWD did not result in brain accumulation of PrPsc during primary passage in 
ovinized mice (Tg338). One factor that may have contributed to the lack of trans-
mission could be varying levels of PrPsc and PrPCWD between brain homogenates 
from animals with scrapie and CWD, respectively [119].
Non-Tg mice have been described as resistant to CWD infection [115], while the 
VM/Dk inbred strain of mice infected with wapiti CWD prions reported limited 
infection [29], suggesting the existence of some variable species barriers to the 
transmission of CWD [77].
Nalls et al. [93] have demonstrated mother-to-offspring transmission and 
disease progression to a viable cohort of offspring that were born to CWD-infected 
dams.
Several researchers noted that dissimilarity between PrP sequences alone does 
not accurately predict the transmissibility between species and other factors are 
under investigation. One that was used in recent studies was the conformational 
selection model, which proposes that compatibility between the three-dimensional 
molecular shapes of PrPsc and PrPc is more important than the sequences of the 
protein backbones [136].
5. Pathogenesis of CWD: the interaction of prions and immune system
The unique features of prions as infectious agents are also blatant when con-
sidering its interaction with the host’s immune system. As stated previously, PrPc 
is involved in important neurologic functions; however, the depletion of neuronal 
PrPc in experimental models, such as mice, cows, and goats, did not result in 
altered phenotypes [11]. This suggests the existence of redundant mechanisms 
that compensate the absence of PrPc, albeit its ubiquitous cellular expression. 
Pertaining the immune system, PrPc is expressed in lymphocytes, granulocytes, 
and stromal cells. This abundant expression may explain why PrPsc does not elicit 
specific immune responses despite its accumulation in high levels within the host’s 
secondary lymphoid tissues (SLT) in the initial phases of the infection. In par-
ticular, gut-associated lymphoid tissues (GALT), such as the Peyer’s patches in the 
small intestine, seem to be pivotal for the infection and disease process. As in most 
natural occurring prion diseases, CWD of cervids is acquired peripherally, mainly 
after oral exposure, after which prions replicate in GALT. The importance of 
GALT in the pathogenesis of prion diseases is well documented by several studies 
that revealed impaired neuroinvasion in the absence of Peyer’s patches [137–140].
5.1 M cells
Within GALT, studies suggest that prions depend on host M cells to enter the 
organism, as they seem to be involved in the initial transfer of the prion agent across 
the gut epithelium. These are specialized epithelial cells widely spread among the 
follicle-associated epithelium, which are involved in the transcytosis of particulate 
antigens and microorganisms from the gut lumen into the GALT [141]. M cells are 
essential to the gut immune system being fundamental to antigen recognition and 
presentation of pathogens or commensal microflora. As such, factors that increase 
M-cell density in the gut epithelium (coinfections or miscellaneous inflammatory 
conditions) may also increase susceptibility to orally acquired prion infections. 
A study by Wyckoff et al. [142] mentions the binding of prions to certain types 
of soil particles that may result in an increased uptake of prions from the gut 
lumen, but it is not yet clear if this uptake is mediated by M cells. Host infection by 
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M-cell-independent mechanisms cannot be disregarded, namely, those involving 
directly enterocytes from the follicle-associated epithelium [143] or other M-cell-
independent pathways [144].
5.2 Follicular dendritic cells (FDC) and B and T lymphocytes
Several studies show that in prion-infected hosts, high accumulations of 
disease-specific PrP are detectable within the B-cell follicles of the SLT [145–149]. 
After internalization, evidence suggests that prions accumulate and replicate in 
the follicular dendritic cells (FDC) that lie in the B-cell follicles and germinal 
centers of SLT [150–156]. FDC possess multiple slender and long dendritic pro-
cesses, differentiate from ubiquitous perivascular precursor cells (pericytes), 
and are a distinct lineage from bone marrow-derived conventional dendritic cells 
(DC) [157, 158]. FDC extend throughout the B-cell follicle being able to trap and 
retain large amounts of native antigens upon their surfaces in the form of immune 
complexes composed by antigen–antibody and/or opsonizing complement com-
ponents. Apparently, prions can be bound by opsonizing complement components 
[152–155], internalized, and replicated within FDC, as it was demonstrated that 
they accumulate upon PrPc-expressing FDC in the SLT of experimentally infected 
mice, sheep with natural scrapie, cervids with CWD, and patients with vCJD 
[145–149]. Subsequently, immunohistochemistry studies identified FDC as the 
first sites of prion conversion and replication in experimentally infected mice, in 
which increased prion labeling was observed on the plasma membranes of FDC in 
the Peyer’s patch germinal centers [143]. Furthermore, evidence suggests that FDC 
maturation and regression cycle are impaired by disease-associated prion protein, 
thus affecting immune function [159]. Despite this, some prion strains can establish 
infection within SLT regardless of FDC, as it was demonstrated by experimental 
studies in mice, where infection occurred associated to the high endothelial venules 
in the lymph nodes [160].
The role of B and T cells in prion disease pathogenesis remains uncertain. 
Experimental studies showed that mice lacking mature B and T cells were not 
susceptible to peripheral infection with prions [145, 161–163], despite prion disease 
pathogenesis being unaffected in T-deficient mice [162, 164, 165]; however, it seems 
that prions are not capable of replicating within B and T cells [166, 167]. These 
cells appear to be intermediary actors in prion diseases, by providing physical and 
humoral support to other cells, thus contributing to the homeostatic state of the 
immune system. However, B cells, in particular, seem to play a more active role 
during prion infection. The ability of secreting tumor necrosis factor-α (TNF-α) 
and lymphotoxins (LT) turns B cells pivotal in keeping FDC in their differentiated 
state, since in the absence of stimulation from these cytokines, FDC rapidly dedif-
ferentiate [168]. In Peyer’s patches, B cells migrate to the mesenteric lymph nodes 
and then return to the circulation [169]. It is this constant rotation between Peyer’s 
patches and SLT that may help B cells to disseminate prions acquired from FDC as 
they both migrate together through the germinal centers [170, 171]. Additionally, 
the accumulation of prions in the spleen and subsequent neuroinvasion are signifi-
cantly decreased in the specific absence of B cells [162]. It is also noteworthy that 
prions were detected in B cells from the blood of sheep with scrapie [172] and deer 
with CWD [173].
As it was already mentioned, FDC in the Peyer’s patches are major sites of early 
prion replication in orally infected animals, both experimentally [137–140, 174] 
and in the natural forms of the disease. The study of natural scrapie cases in sheep 
showed that GALT of the upper gastrointestinal tract exhibited early accumulation 
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of prions when compared to the large intestinal GALT, such as the cecal patches 
[175–178]. The rectoanal mucosa-associated lymphoid tissues (RAMALT), which 
also accumulate prion in naturally occurring cases of scrapie in sheep and goats, as 
well as in CWD in cervids, also displayed reduced incidence of prion accumulation 
at the earlier stages of disease [96, 179–184]. Taken together, these studies point out 
to the fact that prions first replicate within the GALT of the upper gastrointestinal 
tract and then spread to the local lymph nodes and to other SLT, such as the spleen. 
Additionally, it was observed that FDC in the spleen expressing PrPc were able 
to display high levels of prion replication that was impeded after PrPc expression 
blockage in these cells [185].
5.3 Mononuclear phagocytic cells
A heterogeneous population comprised of monocytes, conventional dendritic 
cells (DC), and macrophages seem to have also an important role in host infection. 
From a different lineage of the stromal-derived FDC, conventional DC [157, 158, 186], 
the antigen-presenting cells par excellence, are also involved in the transport of 
antigens both within Peyer’s patches and toward the mesenteric lymph nodes 
[187–189]. Their strategic position allows them not only to sample their local 
environment for pathogens and their antigens, processing them, but also to capture 
and retain unprocessed (native) antigens [190, 191]. Processed or native antigens 
are then delivered to B and T cells as DC undergo maturation and migrate toward 
the local SLT to initiate an immune response [190–193]. Prions are wrapped by DC 
either by complement opsonization, namely, by C1q and C3 components [155, 194],  
or in a non-specifically manner, through fluid-phase micropinocytosis [144]. 
Specific chemokines have been reported to play important roles in prion infec-
tions by regulating FDC and DC migration within the SLT. CXCL13 chemokine is 
expressed by FDC and other stromal cells in the B-cell follicles of SLT and recruits 
CXCR5-expressing cells toward them [195, 196]. On the other hand, CXCL13-
CXCR5 signaling mediates the migration of certain populations of DC toward 
the FDC-containing B-cell follicles [192, 193, 197], and studies have shown that 
the early accumulation of prions upon FDC in Peyer’s patches was impaired and 
disease susceptibility reduced, in the absence of CXCR5 expression by DC [198]. 
The interplay between FDC and DC during prion infection was also patent by the 
finding that early replication of prions upon FDC in the local SLT was inhibited 
when conventional DC were transiently depleted at the time of exposure [199–202]. 
Apparently, after being transferred across the gut epithelium either directly by 
enterocytes or by M cells, prions may be then internalized by DC [143, 199] and 
propagated by them toward FDC in Peyer’s patches [198]. The ability of DC to 
migrate into B-cell follicles [192, 193, 203] suggests that they may also propagate 
prions to and within SLT, namely, to the mesenteric lymph nodes.
Regardless of FDC and DC roles in the propagation of prions, there are other cell 
populations that appear to phagocytose and destroy them [204, 205]. In fact, it was 
observed that tingible body macrophages of the germinal centers display heavy PrPsc 
accumulations within their endosomal compartments during prion disease [143, 159, 
185]. It is speculated that macrophages may scavenge and degrade prions in an attempt 
to protect the host from infection, as it is suggested by studies that show that macro-
phage depletion resulted in an enhanced accumulation of PrPsc within SLT [206, 207].
5.4 Neuroinvasion
After being acquired orally, prions undergo replication and accumulation 
upon FDC, reaching a threshold above which neuroinvasion occurs. Experiments 
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in which immunohistochemical tracing was performed revealed that prions then 
infect enteric nerves and spread along efferent fibers of both the sympathetic 
(e.g., splanchnic nerve) and parasympathetic (e.g., vagus nerve) nervous systems, 
spreading within them to the CNS, where they ultimately cause neurodegeneration 
[143, 208–212]. The initial transfer of prions from FDC to the peripheral nerves 
continues surrounded by knowledge gaps, but it appears that tunneling nanotubes 
(TNT) may play an important role at this stage of the disease. These are slender 
membrane-bound cylinders of cytoplasm that connect cells to enable cell-to-cell 
communication and the intercellular transfer of plasma membrane or cytoplasmic 
components [213]. Since mononuclear phagocytes and DC are in close proximity 
with enteric nerves [214–217] and in vitro studies showed that prions can be trans-
ferred between DC and neurons via endolysosomal vesicles within TNT [215–218], 
it is possible that the same transfer also occurs in vivo. Another hypothesis is that 
the transfer of prions may also occur in association with small endosomal-derived 
vesicles, termed exosomes [219], as it was demonstrated experimentally. Studies 
supporting this theory are based on the observation that DC infected with prions 
can release exosomes that in turn may infect neighboring cells [220]. In the CNS, 
prion aggregates accumulate to a point where they overcome the structures within 
it, starting from the synapses and then proceeding to axons, where axonal retrac-
tion is observed, and then to the cell body, in which atrophy and neuronal loss are 
lastly observed [221–224]. The abovementioned process is, however, slowly and 
progressive, depending on factors such as prion agent strains, the existence of 
concurrent infections, and hosts’ age and immune status [144].
The onset of neurodegeneration is preceded by the activation of glial cells, 
microglia, and astrocytes [225, 226]. Microglial cells, in particular, by intervening in 
synaptic remodeling and in the removal of dead and dying cells, are important for 
the course of neurological changes during prion infection. Organotypic cerebellar 
culture devoid of microglia exhibited enhanced prion accumulation [227], whereas 
CNS prion disease pathogenesis was exacerbated in vivo in the absence of microglia 
[228]. Studies revealed that during prion infections, a cytokine response mediated 
by TGF-β and PGE2 develops within the CNS, stimulating microglia to adopt an 
anti-inflammatory status [223, 229, 230]. Evidence suggests that this anti-inflam-
matory ambiance may be beneficial for the host, as CNS prion infection in mice 
deficient in the anti-inflammatory cytokines interleukin (IL)-4, IL-10, and IL-13 
displays an aggravated disease pathogenesis [231, 232]. Other studies supported 
this hypothesis by the finding that blocking colony-stimulating factor (CSF) recep-
tor-1 resulted in the expression of selective anti-inflammatory microglial markers, 
slowing the development of neuropathology and extending survival times [233]. 
Activated microglia scavenge and clear prions and prion-affected cells, but neural 
degeneration seems to occur when prion accumulation is associated to an inflamma-
tory response in the microglia [234]. Together, these data point out to the existence 
of both anti-inflammatory and pro-inflammatory responses by microglial cells 
during CNS prion infections [226, 234] contributing to the symptoms of this disease.
6. Diagnosis of CWD
Classification of CWD as TSE required histopathological examination of brains 
from diseased animals [60]. These subsequent analyses [80] were limited to micro-
scopic evaluation of the CNS to detect neuropathological features typical of, but not 
necessarily exclusive to, prion diseases including neuronal vacuolation, attendant 
spongiform degeneration of the neuropil, reactive astrocytic gliosis, and florid 
amyloid plaques.
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6.1 Clinical signs and macroscopic lesions
The main clinical features of progressive CWD disease in adults is weight loss and 
behavioral changes that typically span weeks or months. Besides weight loss, diseased 
animals may show a wide range of behavior changes for a long time that include 
somnolence, lassitude, repetitive walking, polydipsia, and polyuria. Gradually, the 
affected cervids may exhibit ataxia, mainly in the hind limbs, head tremors, drooped 
ears, and fixed gaze, and may have difficulty in swallowing. In the end stage, they may 
show signs of sialorrhea and teeth grinding [235, 236]. The clinical signs may be subtle 
requiring that the animal keeper/observer is familiar with and has some knowledge of 
the normal behavior of the species. As a result, the disease is most commonly detected 
in emaciated cervids hunted, killed, or injured by road accidents or found dead [235].
At necropsy, severe emaciation, poor hair coat condition, megaesophagus, froth 
or watery rumen contents (often containing sand), abomasal or omasal ulcers, 
serous atrophy of bone marrow and pericardial fat, enlarged adrenal glands, muscle 
atrophy [237], and aspiration pneumonia are common findings. As the clinical signs 
and the macroscopic findings at necropsy are not pathognomonic [49], other dis-
eases must be ruled out, namely, listeriosis, meningoencephalitis, brain abscesses, 
starvation, nutritional deficiencies or severe parasitism, bluetongue disease, 
epizootic hemorrhagic disease, meningeal worms (Parelaphostrongylus tenuis), and 
locoweed intoxication [49, 235, 238].
TSEs present very specific diagnostic challenges because of their strain varia-
tion, their very long incubation period, and the lack of pathognomonic clinical 
signs. Moreover, the disease pathogenesis can range both among and within species 
due to the influence of strain, host genotype, or a combination of the two [239].
6.2 Rapid screening testing
The initial diagnosis of TSE in all species was based on passive surveillance (e.g., 
clinical presentation) and assessment via conventional histopathology and subse-
quently detection of PrPsc by IHC, both time-consuming, technically demanding, 
and expensive for large surveillance plans [77]. For that reason, the development 
of commercial rapid immunologically based screening tests (RT) for the detection 
of PrPsc in tissue homogenates allowed a large-scale active surveillance program for 
TSE in cattle and small ruminants.
These were originally developed for the detection of BSE in the cattle brain, 
and extensive formal test evaluation of a wide range of these RT was undertaken 
at Europe level [240, 241]. Mainly, there are two types of these RT kits allowing 
the purification, concentration, and detection of PrPsc from samples of tissues 
obtained from infected animals. Both assays consisted in an immuno-enzymatic 
technique: one is a sandwich format using two antibodies for the detection of the 
antigen PrPsc after proteinase K digestion (e.g., TeSeE BioRad®), and the other uses 
a PrPsc-specific ligand immobilized on the surface of the antigen-capture plate (e.g., 
HerdCheck IDEXX®). Both are suitable for the surveillance of CWD as diagnostic 
methods for the detection of the disease [77].
The limited experience in CWD so far in Europe has not allowed us to know the 
best tissue to be proposed as the most sensitive for surveillance in all circumstances. 
Sampling only the brain stem could reduce the diagnostic sensitivity for strain-
host combinations that are characterized by early lymphoid PrPsc accumulation. 
Consequently, lymphoid tissues (preferably the tonsils, retropharyngeal lymph 
nodes, and lymphoid tissues of rectal mucosa) and the brain stem at the level of 
the obex should be tested to maximize the diagnostic sensitivity in any surveillance 
program [77].
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6.3 Confirmatory testing
Like in other recognized animal TSEs, confirmation of an initial CWD “screen-
ing positive” (or “suspect”) sample can be undertaken by histopathological exami-
nation and immunodetection methods either by IHC or Western blot (WB). The 
former enables PrPsc accumulations to be assessed regarding the types of deposition 
and anatomical distribution (including cellular) location, while the latter gives 
some classification data based on the molecular mass and glycosylation profiles of 
the PrPsc [77].
Histopathologic lesions in the encephalon are similar to those described for 
ruminant TSEs: perikaryon neuronal vacuoles, microcavitation of the gray mat-
ter, astrogliosis, neuronal degeneration and loss, and PrP positively labeled prion 
deposits and plaques [242]. Duration of clinical disease does not significantly affect 
the distribution or severity of lesions, and inflammatory cell response is not appar-
ent, unless associated with intercurrent disease [49]. In clinically affected cervids, 
examination of well-fixed medulla oblongata at the level of the obex is considered 
sufficient for diagnosis of CWD [80], and sections at this level were used for CWD 
surveillance before availability of immunohistochemistry [49].
Neuropathology varies slightly between deer and elk: elk have more severe 
lesions in the thalamus and in some white matter areas. Congo red birefringent 
and PAS-positive amyloid plaques have been seen in the deer brain but not in elk 
[80]. The cerebral cortex and basal ganglia of the elk with CWD show minimal 
fine spongiform degeneration and astrogliosis with focal distribution. The spon-
giform degeneration with astrogliosis is more prominent in the thalamus where 
it forms clusters of coarse vacuoles. Fine spongiosis, often in small clusters, is 
present in the molecular layer of the cerebellum, in dorsal nuclei of the pons, and 
in the substantia gelatinosa of the spinal cord. Occasional large neurons in various 
nuclei of the pons show a vacuole [243]. Amyloid plaques are relatively common 
and can be detected on hematoxylin and eosin (HE)-stained brain sections, most 
prominently and with decreasing frequency, in white-tailed deer, mule deer, and 
elk [49]. Neuronal loss and astrogliosis are minimal except for the molecular layer 
of the cerebellum, which shows rarefaction of granule cells with no indication of 
apoptosis [243].
The PrPsc immunostaining is consistently present in the cerebral cortex, basal gan-
glia, and thalamus. In the cerebellum the immunostaining is present in both molecular 
and granule cell layers as well as in the dentate nucleus. In the pons it is widespread 
over gray structures, whereas in the spinal cord, it is generally confined to the dorsal 
part of the dorsal horns [243]. Patterns of PrPsc deposition in CWD-affected cervid 
brains include perineuronal and perivascular accumulation, extracellular plaques and 
granular deposits, and subependymal and subpial deposition [49] (Figure 5).
Recently, a different neuropathologic phenotype, characterized mainly by 
intraneuronal deposition of PrPsc and few immunostaining at the dorsal motor of 
the vagus nerve, was observed in the putative atypical CWD detected in Norwegian 
moose [31].
Deposition of PrPsc occurs widely in lymphoid tissues (Figure 5) during CWD 
incubation in the absence of histologic lesions in these tissues, resembling classical 
scrapie in small ruminants [149, 244]. Therefore, lymphoid tissues are very useful 
for diagnostic purposes and surveillance. Nevertheless, in the referred atypical 
CWD, no PrPsc was detected in lymphoid tissue [31], similar to that described in 
heterozygote ARR sheep affected with classical scrapie as well as atypical scrapie. 
In those cases, lymphoid tissues infectivity should be further studied like it was in 
atypical scrapie, demonstrating that infectivity can accumulate in lymphoid tissues 
even with no detectable PrPsc [245].
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If histopathological examination cannot be carried out due to poor state of the 
sample and/or IHC results which are not conclusive, then Western immunoblotting 
is the remaining confirmation method available. This technique relies on detergent 
extraction followed by treatment with proteinase K to digest any PrPc and detect 
only PrPsc by a specific antibody presenting bands that correspond to proteins 
within a range of molecular mass from 17 kDa (unglycosylated PrPsc) to 27 kD 
(diglycosylated PrPsc) [238].
Figure 5. 
PrPsc immunohistochemistry in CWD affected deer. (A) Perineuronal and granular deposits in neuropil 
at dorsal vagal nucleus (brainstem), X400; (B) Extracelullar plaque-like deposits (cerebral cortex), 
X200; (C) perivascular type (brainstem), X200; (D) distribution in both molecular and granular layers 
of the cerebellum, X200; (E) and (F) presence of PrPsc in several follicules in a lymph node, X100 and 
X200, respectivelly. (A–D) sections from CWD control samples kindly provided by professor Stefanie Czub 
(Canadian food inspection agency, National Center for animal diseases) in 2003; (E-F) sections from the 
CWD proficiency testing 2008 organized by the European reference laboratory for TSEs (APHA, Weybridge). 
(A-D) specific PrPsc signal was visualized with F99/97.6.1 monoclonal antibody (raised against bovine 
residues 220–225; VMRD Inc., Pullman, WA; 1:1250 dilution) StreptABC-alkaline phosphatase, new Fuchsin 
system (DAKO); (E and F) IHC with 2G11 monoclonal antibody (raised against ovine PrP peptide sequence 
146-R154-R171–182; Institute Pourquier;1:200 dilution). All tissue sections were counterstained with Mayer’s 
hematoxylin.
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WB and IHC allow a comparison of labelling patterns with antibodies that 
recognize different epitopes of the protein and help to clarify specific proteinase K 
cleavage inherent of strains type. This approach forms the basis of the discrimina-
tory testing of small ruminant isolates, to differentiate between isolates that can be 
classified as scrapie, and those that are considered BSE-like by looking at the lower 
molecular weight for the unglycosylated protein band and the ratio of the mono- 
and diglycosylated fragments, for example, between classical, atypical/Nor98, and 
CH1641 scrapie in sheep and goats and BSE and scrapie [246, 247].
The Norwegian atypical CWD (Nor-16CWD) also presented an unusual PrPsc 
electrophoretic pattern distinguishable from previous CWD cases and from known 
ruminant prion diseases in Europe, with the possible exception of sheep CH1641. 
Transmission studies in several rodent models are ongoing to clarify if this different 
phenotype could reflect the presence of a new cervid prion strain in moose from 
Norway [31].
6.4 New diagnostic methods
Regarding diagnosis in vivo, more sensitive diagnostic methods are desirable. 
Using in vitro conversion such as protein misfolding cycling amplification (PMCA) 
or real-time quaking-induced conversion assay (RT-QuIC), CWD prions are detect-
able already at a preclinical stage in specimen that can be obtained antemortem by 
noninvasive methods, such as blood, urine, feces, or saliva.
During PMCA, the normal form of PrP (PrPc) is converted into protease 
K-resistant PrP (PrPsc) using small amounts of infectious PrPsc. Continued recruit-
ment and conversion of PrPc by PrPsc are accomplished by sonication in a process 
analogous to amplification of DNA by the polymerase chain reaction (PCR). This 
amplification process enhances detection sensitivity by several orders of magnitude 
as compared to WB and has been used to confirm the presence of CWD prions in 
muscle [248] and feces [249].
In the assay referred to as real-time quaking-induced conversion (RT-QuIC) 
[250], prion seeds are thought to induce recombinant PrP to adopt a β-sheet 
structure. Thioflavin T, added to the reaction, is incorporated into the grow-
ing amyloid causing an altered spectrofluorimetric emission pattern, which is 
monitored over time.
CWD still represents a challenge in TSE research for which transmission and 
dissemination remain unchecked. The tools of diagnostic available for identifying 
infected animals have steadily progressed over time from clinical and pathological 
descriptions to antibody–antigen-dependent immunoassays and more recently 
qualitative and quantitative prion amplification techniques. These tools have 
provided a deep understanding of disease pathogenesis and transmission and 
allowed animal health technicians to monitor the expanding geographical presence 
of CWD [251].
7. Surveillance and control of CWD
7.1 Surveillance
Of further concern is the fact that CWD is the only transmissible spongiform 
encephalopathy known to be expanding both geographically and in prevalence [5].
After the confirmation in 2016 of two cases of CWD in a wild reindeer (April) 
and a wild moose (May) in Norway (the first CWD cases in Europe), this country 
intensified its surveillance program for CWD in cervids and detected a number 
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of other cases of CWD in reindeers and in moose. In the meantime, the European 
Commission (EC) requested the European Food Safety Agency (EFSA) to recom-
mend surveillance activities and, if necessary, additional animal health risk-based 
measures to prevent the introduction of the disease and the spread into/within the 
European Union (EU), specifically Estonia, Finland, Iceland, Latvia, Lithuania, 
Norway, Poland, and Sweden [252]. Based on EFSA opinion, the EC places in 
force the Commission Regulation (EU) 2017/1972, amending Annexes I and III 
of Regulation (EC) No. 999/2001 as regards a surveillance program for chronic 
wasting disease in cervids in Estonia, Finland, Latvia, Lithuania, Poland, and 
Sweden and repealing Commission Decision 2007/182/EC (which provided require-
ments for a survey on CWD in cervids which was carried out from 2007 to 2010). 
According to this new regulation, the member states (MSs), which have a wild 
and/or farmed and/or semidomesticated population of moose band/or reindeer 
(aforementioned MSs), shall carry out a 3-year monitoring program for CWD from 
1 January 2018 to 31 December 2020.
The 3-year CWD monitoring program shall cover animals over 12 months of 
age, estimated on the basis of dentition, obvious signs of maturity, or any other 
reliable information, of the following cervid species:
• Eurasian tundra reindeer (Rangifer tarandus tarandus)
• Finnish forest reindeer (Rangifer tarandus fennicus)
• Moose (Alces alces)
• Roe deer (Capreolus capreolus)
• White-tailed deer (Odocoileus virginianus)
• Red deer (Cervus elaphus)
According to some authors [252, 253], in order to avoid unbiased prevalence or 
incidence estimates and to obtain a representative set of animals, a random sampling 
is always recommended to design monitoring program. This classical approach may be 
possible to achieve for farmed cervids, but, for wildlife population, random sampling 
may not be possible to design as sampling frames are not available [252]. However, 
when disease detection is the first objective, a sampling targeting high-risk animals 
may be more efficient. That, in fact, was the case of the Norwegian monitoring pro-
gram that detected the two CWD cases through sampling of “suspect” cervids [252].
Since the aims of the proposed surveillance system were to detect disease in 
countries where CWD has not yet been detected and to estimate prevalence in areas 
where disease has been detected, the 3-year surveillance system includes a two-
stage sampling program (Commission Regulation (EU) 2017/1972):
• At the first stage, a random sampling is applied for wild/semidomesticated cer-
vids [primary sampling (PSU)] corresponding to geographical areas containing 
cervid populations, whereas for farmed cervids they will correspond to farms.
• At the second stage, a convenience sampling is applied targeting high-risk 
animals of the selected species within PSU (Figure 6).
To date, according to Commission Regulation (EU) 2017/1972, member states 
shall carry out additional monitoring for TSEs in cervids based on a risk assess-
ment which may take into account the detection of a TSE in cervids in the same or 
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neighboring regions. Efforts to prevent the introduction of CWD should consider 
whether prior surveillance data are sufficient to assure that the disease has not 
already spread into the area of interest.
Based on the main provisions in the TSE regulation currently applicable to 
CWD, TSE-positive cases in cervids must be notified to the commission and the 
member states (Article 11 of Regulation (EC) No. 999/2001), and all parts of the 
body of a cervid positive for TSE must be sent to disposal as category 1 materi-
als in accordance with the Animal By-Product Regulation 10 (Article 13.1. (a) of 
Regulation (EC) No. 999/2001).
7.2 TSE control
As it was previously referred (see Section 4), CWD is a very contagious form of 
TSE. Therefore, control in captive cervids is not easy and even more in the wildlife. 
According to Uehlinger and colleagues [254], the combination of direct and environ-
mental transmission of CWD prions; the persistence of environmental infectious prion 
for at least for 2.5 years [255]; the absence of a rapid, practical, and reliable antemortem 
field tests for detecting preclinical CWD; and the nonavailability of licensed vaccines nor 
therapies together with the impossibility of quarantine suspicions populations in wild 
cervids make the control of this disease in wild populations very difficult.
The management of CWD in affected populations is a proven difficult task, 
based on population reduction in the case of wild deer or in quarantine and depop-
ulation in commercially reared animals.
Measures to control the spread of the disease will depend on whether we are 
dealing with commercially exploited herds, confined to demarcated areas, or with 
wild populations of deer. In the first case, and similar to other infectious diseases and 
other livestock, programs to detect and eliminate positive animals may be used [94].
This task is not easy, however, as a shown by a 2018 study conducted on a private 
farm in Colorado where the use of disease control management through rectal 
biopsy diagnosis was not able to prevent the increase in prevalence suggesting the 
need to refine management criteria or antemortem diagnostic methods [5].
Thus, the science available to inform effective CWD management and control 
strategies remains relatively incomplete as it was concluded by different studies 
[254, 256] during their review on CWD control in North America. Nevertheless, 
it may be stated that approaches for CWD management generally fall into three 
categories in order to prevent the introduction of the disease and its spread [252]:
a. Prevention of entry in free regions (where CWD is assumed absent or is not 
believed to occur)
b. Containment procedures of a CWD focus to avoid disease spread
c. Control/suppression in an affected herd or population
Regarding preventive and containment strategies, it was referred that these 
measures tend to focus on regulations (e.g., bans on movements of live animals, 
carcasses, or specified risk materials) and efforts to prevent the introduction of 
CWD should consider whether prior surveillance data are sufficient to assure that 
the disease has not already spread into the area of interest [252].
Haley and collaborators [94] suggest that outer mechanisms of disease 
control could be useful like the development of simple antemortem test to use 
prior to animal movements among farms, the breeding for resistant genotypes, 
the installation of effective fences to prevent transmission between commercial 
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and wild populations, and equipment cleaning and quarantine prior to animal 
introduction.
Free-ranging deer population reduction is empirically effective in reducing a 
disease with direct contact transmission, but several studies have shown that in the 
case of CWD, the results are below expected [94, 257].
Capturing, testing, and recapturing positive free-ranging mule deer did not 
reduce prevalence in the female population [258].
Concerning the prevention of entry in free regions, according to Regulation 
(EC) No. 999/2001, in the EU, the feeding to cervids of proteins derived from 
animals is prohibited, with the exception of milk and milk products, eggs and egg 
products, hydrolyzed proteins from nonruminants or from ruminant hides and 
skins, and gelatine and collagen from nonruminants (Article 7 and Annex IV). Also, 
at import into the EU, an attestation is required for meat and meat products from 
wild and farmed cervids coming from the USA or Canada (Chapter F of Annex IX), 
confirming that the products:
• Exclude the offal and spinal cord
• Are derived from animals tested for CWD with negative results
• Are derived from animals which do not come from a herd (for farmed animals) 
or a region (for wild animals) where CWD has been confirmed or officially 
suspected
As a result of the detection of the first case in Norway, in Europe, in addition 
to the permanent measures as described in the aforementioned regulation, the 
Commission Implementing Decision (EU) 2016/1918 enforced temporary safe-
guard measures in relation to CWD (until December 31, 2017). According to this 
Figure 6. 
Surveillance program for CWD in cervids. Schematic presentation of two-stage sampling approach of the 
3-year surveillance programme for CWD in cervids in Estonia, Finland, Latvia, Lithuania, Poland and 
Sweden in cervids defined on commission regulation (EU) 2017/1972.
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decision, the movement of live cervids from Norway into the European Union 
was prohibited with several derogations permitting its movements under certain 
circumstances (e.g., movements of live cervids from Norway to Sweden or Finland 
for direct slaughter; movements of live reindeer for seasonal grazing from Norway 
to some listed areas in Sweden and Finland).
According to the European Food Safety Agency [252], the derogations that lay 
down in this decision present a risk of introduction of CWD into the EU, since 
it was concluded that the most likely pathway of introduction of CWD into the 
EU is the movement of live cervids, either by deliberate transportation or by the 
movement of wild animals across the border of Norway to Sweden or Finland. 
Additionally, these authors present other measures to reduce the probability of 
introduction of CWD into the EU, namely, the use of natural cervid urine lures and 
awareness campaigns targeting both local Norwegian hunters and hunters visiting 
Norway from (and returning to) other countries regarding the personal protective 
equipment (PPE), disinfection, the safe dressing of carcasses, and the appropriate 
disposal of carcass trimmings.
In general, according to several authors [252, 254, 256], other measures can be 
implemented in order to contain and/or to control/suppress CWD in a region or 
country where the disease is present. Some of those measures may include:
• Reducing environmental contamination (e.g., interdict the use of dead cervids 
to feed wildlife nor to use as baits for hunting, unless they have been tested 
negative, prior to use).
• Reduction of animal-to-animal contact (e.g., ban artificial feeding, lick blocks 
or other congregating management procedures).
• Decrease population densities by definition of strategic plan for hunting 
management policies (e.g. increasing harvest permits and/or hunting season) 
and culling practices.
Regarding the last measure (decrease population), Uehlinger and colleagues 
[254] alert that:
• To date, the evidence is unclear that increased nonselective culling pressure has 
a beneficial effect on the spread or prevalence of CWD.
• Culling of wildlife is often unpopular. For that reason, any control program 
that includes culling of animals must take into account the public acceptance 
and hunters’ attitudes and behaviors.
Since dispersion of infected deer may not be limited by political boundaries, 
regional and interstate/interprovincial cooperation and collaboration will be an 
important part of any successful management strategy. Also, it is always important 
to evaluate the costs in order to understand the feasibility of the control strategy 
proposals (when developing any intervention program) [254].
This review gathers known and recent features of this progressive and fatal 
neurodegenerative disease affecting cervid species, contributing for chronic wast-
ing disease awareness among scientific community and stakeholders. Conscious 
that research in this field has a long way to go to answer many of the questions that 
remain open, we believe that this review will contribute to the understanding of the 
occurrence of prion diseases in wildlife.
Wildlife Population Monitoring
26
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
Author details
Carla Neves Machado1, Leonor Orge1,2, Isabel Pires2, Adelina Gama2, 
Alexandra Esteves2, Ana Paula Mendonça1, Ana Matos3, Anabela Alves2, 
Carla Lima1, Estela Bastos4, Fernanda Seixas2, Filipe Silva2, João Carlos Silva1, 
Luis Figueira3, Madalena Vieira-Pinto2, Maria De Lurdes Pinto2,  
Nuno Gonçalves-Anjo5, Paula Tavares1, Paulo Carvalho1, Roberto Sargo2  
and Maria Dos Anjos Pires2*
1 Pathology Laboratory, UEISPSA, National Institute for Agricultural and 
Veterinary Research (INIAV), Oeiras and Vila do Conde, Portugal
2 Animal and Veterinary Research Centre (CECAV), University of Trás-os-Montes 
and Alto Douro (UTAD), Vila Real, Portugal
3 Polytechnic Institute of Castelo Branco (IPCB), Castelo Branco, Portugal
4 Centre for the Research and Technology of Agro-Environmental and Biological 
Sciences (CITAB), University of Trás-os-Montes and Alto Douro (UTAD),  
Vila Real, Portugal
5 Genetics and Biotechnology Department, University of Trás-os-Montes and Alto 
Douro (UTAD), Vila Real, Portugal
*Address all correspondence to: apires@utad.pt
Acknowledgements
We would like to thank Professor Jesus R. Requena (CIMUS Biomedical 
Research Institute and Department of Medical Sciences, University of Santiago de 
Compostela-IDIS, Spain) for his critical review in the description of the structure of 
PrPsc in the Biology of the etiologic agent section.
27
TSE Monitoring in Wildlife Epidemiology, Transmission, Diagnosis, Genetics and Control
DOI: http://dx.doi.org/10.5772/intechopen.85797
[1] Wood J, Lund L, Done S. The natural 
occurrence of scrapie in moufflon. The 
Veterinary Record. 1992;130:25-27
[2] Pitarch J, Raksa H, Arnal M, Revilla 
M, Martínez D, Fernández de Luco D, 
et al. Low sequence diversity of the 
prion protein gene (PRNP) in wild deer 
and goat species from Spain. Veterinary 
Research. 2018;49(1):33
[3] Peletto S, Perucchini M, Acin C, 
Dalgleish M, Reid H, Rasero R, et al. 
Genetic variability of the prion protein 
gene (PRNP) in wild ruminants from 
Italy and Scotland. Journal of Veterinary 
Science. 2009;10:115-120
[4] Hadjisterkotis E, editor The Cyprus 
Mouflon, a threatened species in 
a biodiversity “hotspot” area. In: 
Proceedings of the International 
Mouflon Symposium; Sopron, Hungary. 
2001
[5] Haley NJ, Henderson DM, Wycoff 
S, Tennant J, Hoover EA, Love D, et al. 
Chronic wasting disease management in 
ranched elk using rectal biopsy testing. 
Prion. 2018;12(2):93-108
[6] Prusiner S. Biology and genetics 
of prions causing neurodegeneration. 
Annual Review of Genetics. 
2013;47:601-623
[7] Riesner D. The Prion theory: 
Background and basic information. 
In: Rabenau HF, Ciantl J, Doherr HW, 
editors. Prions—A Challenge for 
Science, Medicine and Public Health 
System Contributions to Microbiology. 
Vol. 7. Basel: Karger; 2001. pp. 7-20
[8] Aguilar-Calvo P, García C, Espinosa 
JC, Andreoletti O, TJ M. Prion and 
prion-like diseases in animals. Virus 
Research. 2015;207:82-93
[9] Requena J, Wille H. The structure 
of the infectious prion protein 
Experimental data and molecular 
models. Prion. 2014;8:1-7
[10] Wille H, Requena J. The structure of 
PrPSc prions. Pathogens. 2018;7:20
[11] Wulf MA, Senatore A, Aguzzi 
A. The biological function of the 
cellular prion protein: An update. BMC 
Biology. 2017;15(1):34
[12] Dormont D. Prion diseases: 
Pathogenesis and public health 
concerns. FEBS Letters. 2002;529:17-21
[13] Huang Z, Prusiner S, Cohen 
F. Scrapie prions: A three-dimensional 
model of an infectious fragment. 
Folding and Design. 1996;1:13-19
[14] Riek R, Hornemann S, Wider G, 
Billeter M, Glockshuber R, Wüthrich 
K. NMR structure of the mouse prion 
protein domain PrP(121-231). Nature. 
1996;382:180-182
[15] Downing D, Lazo N. Molecular 
modelling indicates that the 
pathological conformations of prion 
proteins might be beta-helical. The 
Biochemical Journal. 1999;343:453-460
[16] Wille H, Michelitsch M, Guenebaut 
V, Supattapone S, Serban A, Cohen 
F, et al. Structural studies of the 
scrapie prion protein by electron 
crystallography. Proceedings of 
the National Academy of Sciences 
of the United States of America. 
2002;99:3563-3568
[17] Mornon J, Prat K, Dupuis F, 
Boisset N, Callebaut I. Structural 
features of prions explored by 
sequence analysis. II. A PrP(Sc) model. 
Cellular and Molecular Life Sciences. 
2002;59:2144-2154
[18] DeMarco M, Daggett V. From 
conversion to aggregation: Protofibril 
formation of the prion protein. 
References
Wildlife Population Monitoring
28
Proceedings of the National Academy 
of Sciences of the United States of 
America. 2004;101:2293-2298
[19] Govaerts C, Wille H, Prusiner 
S, Cohen F. Evidence for assembly 
of prions with left-handed beta-
helices into trimers. Proceedings of 
the National Academy of Sciences 
of the United States of America. 
2004;101:8342-8347
[20] Stork M, Giese A, Kretzschmar 
H, Tavan P. Molecular dynamics 
simulations indicate a possible role 
of parallel beta-helices in seeded 
aggregation of poly-Gln. Biophysical 
Journal. 2005;88:2442-2451
[21] Yang S, Levine H, Onuchic J, Cox 
D. Structure of infectious prions: 
Stabilization by domain swapping. The 
FASEB Journal. 2005;19:1778-1782
[22] Langedijk J, Fuentes G, Boshuizen 
R, Bonvin A. Two-rung model of 
a left-handed beta-helix for prions 
explains species barrier and strain 
variation in transmissible spongiform 
encephalopathies. American 
Journal of Molecular Biology. 
2006;360:907-920
[23] Cobb N, Sönnichsen F, McHaourab 
H, Surewicz W. Molecular architecture 
of human prion protein amyloid: A 
parallel, in-register beta-structure. 
Proceedings of the National Academy 
of Sciences of the United States of 
America. 2007;104:18946-18951
[24] Groveman B, Dolan M, Taubner 
L, Kraus A, Wickner R, Caughey 
B. Parallel in-register intermolecular 
β-sheet architectures for prion-seeded 
prion protein (PrP) amyloids. The 
Journal of Biological Chemistry. 
2014;289:24129-24142
[25] Kunes K, Clark S, Cox D, Singh 
R. Left handed beta helix models 
for mammalian prion fibrils. Prion. 
2008;2:81-90
[26] Vázquez-Fernández E, Vos M, 
Afanasyev P, Cebey L, Sevillano A, Vidal 
E, et al. The structural architecture 
of an infectious mammalian prion 
using electron cryomicroscopy. PLoS 
Pathogens. 2016;8:e1005835
[27] Angers R, Kang H, D N BS, 
Seward T, Mathiason C, et al. Prion 
strain mutation determined by prion 
protein conformational compatibility 
and primary structure. Science. 
2010;328:1154-1158
[28] Benestad S, Telling G. Chronic 
wasting disease: An evolving prion 
disease of cervids. In: Pocchiari M, 
Manson J, editors. Handbook of Clinical 
Neurology, Human Prion Diseases. Vol. 
153. Amsterdam: Elsevier BV; 2018. pp. 
135-151
[29] Lee YH, Sohn HJ, Kim MJ, Kim HJ, 
Park KJ, Lee WY, et al. Experimental 
chronic wasting disease in wild type VM 
mice. The Journal of Veterinary Medical 
Science. 2013;75(8):1107-1110
[30] Benestad S, Mitchell G, Simmons 
M, Ytrehus B, Vikøren T. First case of 
chronic wasting disease in Europe in 
a Norwegian free-ranging reindeer. 
Veterinary Research. 2016;47:88
[31] Pirisinu L, Tran L, Chiappini 
B, Vanni I, Di Bari MA, Vaccari G, 
et al. Novel type of chronic wasting 
disease detected in moose (Alces alces), 
Norway. Emerging Infectious Diseases. 
2018;24(12):2210-2218
[32] Martin S, Jeffrey M, Gonzalez 
L, Siso S, Reid HW, Steele P, et al. 
Immunohistochemical and biochemical 
characteristics of BSE and CWD in 
experimentally infected European red 
deer (Cervus elaphus elaphus). BMC 
Veterinary Research. 2009;5:26
[33] Kurt TD, Jiang L, Fernández-Borges 
N, Bett C, Liu J, Yang T, et al. Human 
prion protein sequence elements impede 
cross-species chronic wasting disease 
29
TSE Monitoring in Wildlife Epidemiology, Transmission, Diagnosis, Genetics and Control
DOI: http://dx.doi.org/10.5772/intechopen.85797
transmission. The Journal of Clinical 
Investigation. 2015;125(4):1485-1496
[34] Crick F. Central dogma of molecular 
biology. Nature. 1970;227(5258): 
561-563
[35] Manning KS, Cooper TA. The 
roles of RNA processing in translating 
genotype to phenotype. Nature 
Reviews. Molecular Cell Biology. 
2017;18(2):102-114
[36] Prusiner SB. Molecular structure, 
biology, and genetics of prions. In: 
Maramorosch K, Murphy FA, Shatkin 
AJ, editors. Advances in Virus Research. 
Vol. 35. Cambridge, Massachusetts: 
Academic Press; 1988. pp. 83-136
[37] Chakravarty AK, Jarosz 
DF. More than just a phase: Prions 
at the crossroads of epigenetic 
inheritance and evolutionary change. 
Journal of Molecular Biology. 
2018;430(23):4607-4618
[38] Baskakov IV, Breydo 
L. Converting the prion protein: 
What makes the protein infectious. 
Biochimica et Biophysica Acta 
(BBA)—Molecular Basis of Disease. 
2007;1772(6):692-703
[39] Fujun F, Lanhui L, Xianglong L, 
Xiangyun L, Rongyan Z. Evolution and 
differentiation of the prion protein gene 
(PRNP) among species. The Journal of 
Heredity. 2008;99(6):647-652
[40] Robinson SJ, Samuel MD, 
O’Rourke KI, Johnson CJ. The role of 
genetics in chronic wasting disease 
of North American cervids. Prion. 
2012;6(2):153-162
[41] O’Rourke KI, Baszler TV, Miller 
JM, Spraker TR, Sadler-Riggleman I, 
Knowles DP. Monoclonal antibody 
F89/160.1.5 defines a conserved 
epitope on the ruminant prion protein. 
Journal of Clinical Microbiology. 
1998;36(6):1750-1755
[42] Owen F, Poulter M, Collinge J, 
Crow TJ. Codon 129 changes in the 
prion protein gene in Caucasians. The 
American Journal of Human Genetics. 
1990;46(6):1215-1216
[43] Collinge J, Palmer MS, Dryden 
AJ. Genetic predisposition to iatrogenic 
Creutzfeldt-Jakob disease. The Lancet. 
1991;337(8755):1441-1442
[44] Palmer MS, Dryden AJ, Hughes JT, 
Collinge J. Homozygous prion protein 
genotype predisposes to sporadic 
Creutzfeldt-Jakob disease. Nature. 
1991;352(6333):340-342
[45] O’Rourke KI, Besser TE, Miller 
MW, Cline TF, Spraker TR, Jenny AL, 
et al. PrP genotypes of captive and 
free-ranging Rocky Mountain elk 
(Cervus elaphus nelsoni) with chronic 
wasting disease. The Journal of General 
Virology. 1999;80(Pt 10):2765-2769
[46] O’Rourke KI, Spraker TR, Zhuang 
D, Greenlee JJ, Gidlewski TE, Hamir 
AN. Elk with a long incubation 
prion disease phenotype have a 
unique PrPd profile. NeuroReport. 
2007;18(18):1935-1938
[47] Goldmann W. PrP genetics in 
ruminant transmissible spongiform 
encephalopathies. Journal of Veterinary 
Research. 2008;39(4):30
[48] O’Rourke KI, Spraker TR, 
Hamburg LK, Besser TE, Brayton 
KA, Knowles DP. Polymorphisms in 
the prion precursor functional gene 
but not the pseudogene are associated 
with susceptibility to chronic wasting 
disease in white-tailed deer. The Journal 
of General Virology. 2004;85(Pt 
5):1339-1346
[49] Williams ES. Chronic wasting 
disease. Journal of Veterinary Pathology. 
2005;42:530-549
[50] Huson HJ, Happ GM. 
Polymorphisms of the prion protein 
Wildlife Population Monitoring
30
gene (PRNP ) in Alaskan moose 
(Alces alces gigas). Animal Genetics. 
2006;37(4):425-426
[51] Jewell JE, Conner MM, Wolfe LL, 
Miller MW, Williams ES. Low frequency 
of PrP genotype 225SF among 
free-ranging mule deer (Odocoileus 
hemionus) with chronic wasting 
disease. Journal of General Virology. 
2005;86(8):2127-2134
[52] Wilson GA, Nakada SM, Bollinger 
TK, Pybus MJ, Merrill EH, Coltman 
DW. Polymorphisms at the PRNP gene 
influence susceptibility to chronic 
wasting disease in two species of 
deer (Odocoileus Spp.) in western 
Canada. Journal of Toxicology and 
Environmental Health. Part A. 
2009;72(17-18):1025-1029
[53] Johnson C, Johnson J, Vanderloo JP, 
Keane D, Aiken JM, McKenzie D. Prion 
protein polymorphisms in white-tailed 
deer influence susceptibility to chronic 
wasting disease. The Journal of General 
Virology. 2006;87(Pt 7):2109-2114
[54] Jeong HJ, Lee JB, Park SY, Song CS, 
Kim BS, Rho JR, et al. Identification of 
single-nucleotide polymorphisms of the 
prion protein gene in sika deer (Cervus 
nippon laiouanus). Journal of Veterinary 
Science. 2007;8(3):299-301
[55] Happ G, Huson H, Beckmen K, 
Kennedy L. Prion protein genes in 
caribou from Alaska. Journal of Wildlife 
Diseases. 2007;43(2):224-228
[56] Perucchini M, Griffin K, Miller 
MW, Goldmann W. PrP genotypes of 
free-ranging wapiti (Cervus elaphus 
nelsoni) with chronic wasting disease. 
The Journal of General Virology. 
2008;89(Pt 5):1324-1328
[57] White SN, Spraker TR, Reynolds 
JO, O’Rourke KI. Association analysis of 
PRNP gene region with chronic wasting 
disease in Rocky Mountain elk. BMC 
Research Notes. 2010;3:314
[58] Heaton MP, Leymaster KA, Freking 
BA, Hawk DA, Smith TPL, Keele JW, 
et al. Prion gene sequence variation 
within diverse groups of U.S. sheep, 
beef cattle, and deer. Mammalian 
Genome. 2003;14(11):765-777
[59] Meng LP, Zhao DM, Liu HX, 
Yang JM, Ning ZY, Wu CD, et al. 
Polymorphisms of the prion protein 
gene (PRNP) in Chinese domestic 
sika deer (Cervus nippon hortulorum). 
Animal Genetics. 2005;36(3):266-267
[60] Williams ES, Young S. Chronic 
wasting disease of captive mule deer: A 
spongiform encephalopathy. Journal of 
Wildlife Diseases. 1980;16(1):89-98
[61] Guiroy DC, Williams ES, Yanagihara 
R, Gajdusek DC. Topographic 
distribution of scrapie amyloid-
immunoreactive plaques in chronic 
wasting disease in captive mule deer 
(Odocoileus hemionus hemionus). Acta 
Neuropathologica. 1991;81(5):475-478
[62] Guiroy DC, Williams ES, Yanagihara 
R, Gajdusek DC. Immunolocalization of 
scrapie amyloid (PrP27-30) in chronic 
wasting disease of Rocky Mountain elk 
and hybrids of captive mule deer and 
white-tailed deer. Neuroscience Letters. 
1991;126(2):195-198
[63] Williams ES, Young S. Spongiform 
encephalopathy of Rocky Mountain 
elk. Journal of Wildlife Diseases. 
1982;18(4):465-471
[64] Williams ES, Young S. Spongiform 
encephalopathies in Cervidae. 
Revue Scientifique et Technique. 
1992;11(2):551-567
[65] Williams ES. Chronic wasting 
disease. Veterinary Pathology. 
2005;42(5):530-549
[66] Benestad SL, Telling GC. Chronic 
wasting disease: An evolving prion 
disease of cervids. Handbook of Clinical 
Neurology. 2018;153:135-151
31
TSE Monitoring in Wildlife Epidemiology, Transmission, Diagnosis, Genetics and Control
DOI: http://dx.doi.org/10.5772/intechopen.85797
[67] Williams ES, Miller MW. Chronic 
wasting disease in deer and elk in 
North America. Revue Scientifique et 
Technique. 2002;21(2):305-316
[68] Haley NJ, Henderson DM, Wycoff 
S, Tennant J, Hoover EA, Love D, et al. 
Chronic wasting disease management in 
ranched elk using rectal biopsy testing. 
Prion. 2018;12(2):93-108
[69] United States Geological Survey 
(USGS). Expanding Distribution of 
Chronic Wasting Disease. https://
www.usgs.gov/centers/nwhc/science/
expanding-distribution-chronic-
wasting-disease?qt-science_center_
objects=0#qt-science_center_objects 
(accessed 25 April 2019)
[70] Centers for Disease Control and 
Prevention: CDC 24/7: Saving Lives, 
Protecting People TM. Chronic Wasting 
Disease: Occurrence. https://www.
cdc.gov/prions/cwd/occurrence.html 
(accessed 25 April 2019)
[71] Kahn S, Dube C, Bates L, 
Balachandran A. Chronic wasting 
disease in Canada: Part 1. The 
Canadian Veterinary Journal. 
2004;45(5):397-404
[72] Ball K. Chronic wasting 
disease in a Rocky Mountain elk. 
The Canadian Veterinary Journal. 
2002;43(11):880-882
[73] Dube C, Mehren KG, Barker IK, 
Peart BL, Balachandran A. Retrospective 
investigation of chronic wasting disease 
of cervids at the Toronto Zoo, 1973-
2003. The Canadian Veterinary Journal. 
2006;47(12):1185-1193
[74] Lapointe JM, Leclair D, Mesher C, 
Balachandran A. Screening for chronic 
wasting disease in caribou in northern 
Quebec. The Canadian Veterinary 
Journal. 2002;43(11):886-887
[75] Canadian Food Inspection 
Agency. Chronic wasting disease 
(CWD) of deer and elk. http://www.
inspection.gc.ca/animals/terrestrial-
animals/diseases/reportable/cwd/
eng/1330143462380/1330143991594 
(accessed 25 April 2019)
[76] Sohn HJ, Kim JH, Choi KS, Nah 
JJ, Joo YS, Jean YH, et al. A case of 
chronic wasting disease in an elk 
imported to Korea from Canada. The 
Journal of Veterinary Medical Science. 
2002;64(9):855-858
[77] Ricci A, Allende A, Bolton D, 
Chemaly M, Davies R, Fernández 
Escámez PS, et al. Scientific opinion 
on chronic wasting disease (II). The 
European Food Safety Authority (EFSA) 
Journal. 2018;16(1):e05132
[78] Gale P, Roberts H. Update on chronic 
wasting disease in europe. department 
for environment. Food and Rural 
Affairs Animal & Plant Health Agency 
Monitoring VSPAT-ID. 2018;2018:25
[79] Joly DO, Ribic CA, Langenberg 
JA, Beheler K, Batha CA, Dhuey BJ, 
et al. Chronic wasting disease in 
free-ranging Wisconsin white-tailed 
deer. Emerging Infectious Diseases. 
2003;9(5):599-601
[80] Williams ES, Young S. 
Neuropathology of chronic wasting 
disease of mule deer (Odocoileus 
hemionus) and elk (Cervus elaphus 
nelsoni). Veterinary Pathology. 
1993;30(1):36-45
[81] Baeten LA, Powers BE, Jewell JE, 
Spraker TR, Miller MW. A natural 
case of chronic wasting disease in 
a free-ranging moose (Alces alces 
shirasi). Journal of Wildlife Diseases. 
2007;43(2):309-314
[82] Race B, Meade-White KD, 
Phillips K, Striebel J, Race R, 
Chesebro B. Chronic wasting disease 
agents in nonhuman primates. 
Emerging Infectious Diseases. 
2014;20(5):833-837
Wildlife Population Monitoring
32
[83] Race B, Meade-White KD, Miller 
MW, Barbian KD, Rubenstein R, 
LaFauci G, et al. Susceptibilities of 
nonhuman primates to chronic wasting 
disease. Emerging Infectious Diseases. 
2009;15(9):1366-1376
[84] Heisey DM, Mickelsen NA, 
Schneider JR, Johnson CJ, Johnson 
CJ, Langenberg JA, et al. Chronic 
wasting disease (CWD) susceptibility 
of several North American rodents 
that are sympatric with cervid CWD 
epidemics. Journal of Virology. 
2010;84(1):210-215
[85] Di Bari MA, Nonno R, Castilla J, 
D'Agostino C, Pirisinu L, Riccardi G, 
et al. Chronic wasting disease in bank 
voles: Characterisation of the shortest 
incubation time model for prion diseases. 
PLoS Pathogens. 2013;9(3):e1003219
[86] Raymond GJ, Raymond LD, Meade-
White KD, Hughson AG, Favara C, 
Gardner D, et al. Transmission and 
adaptation of chronic wasting disease 
to hamsters and transgenic mice: 
Evidence for strains. Journal of Virology. 
2007;81(8):4305-4314
[87] Perrott MR, Sigurdson CJ, Mason 
GL, Hoover EA. Evidence for distinct 
chronic wasting disease (CWD) strains 
in experimental CWD in ferrets. The 
Journal of General Virology. 2012;93 
(Pt 1):212-221
[88] Hamir AN, Miller JM, Cutlip RC, 
Stack MJ, Chaplin MJ, Jenny AL, et al. 
Experimental inoculation of scrapie 
and chronic wasting disease agents in 
raccoons (Procyon lotor). The Veterinary 
Record. 2003;153(4):121-123
[89] Mathiason CK, Nalls AV, Seelig 
DM, Kraft SL, Carnes K, Anderson KR, 
et al. Susceptibility of domestic cats 
to chronic wasting disease. Journal of 
Virology. 2013;87(4):1947-1956
[90] Moore SJ, West Greenlee MH, 
Kondru N, Manne S, Smith JD, Kunkle 
RA, et al. Experimental transmission of 
the chronic wasting disease agent to swine 
after oral or intracranial inoculation. 
Journal of Virology. 2017;91(19)
[91] Hamir AN, Kunkle RA, Cutlip 
RC, Miller JM, Williams ES, Richt 
JA. Transmission of chronic wasting 
disease of mule deer to Suffolk sheep 
following intracerebral inoculation. 
Journal of Veterinary Diagnostic 
Investigation. 2006;18(6):558-565
[92] Hamir AN, Greenlee JJ, Nicholson 
EM, Kunkle RA, Richt JA, Miller JM, 
et al. Experimental transmission of 
chronic wasting disease (CWD) from 
elk and white-tailed deer to fallow 
deer by intracerebral route: Final 
report. Canadian Journal of Veterinary 
Research. 2011;75(2):152-156
[93] Nalls AV, McNulty E, Powers J, Seelig 
DM, Hoover C, Haley NJ, et al. Mother 
to offspring transmission of chronic 
wasting disease in reeves' muntjac deer. 
PLoS One. 2013;8(8):e71844
[94] Haley NJ, Hoover EA. Chronic 
wasting disease of cervids: Current 
knowledge and future perspectives. 
Annual Review of Animal Biosciences. 
2015;3:305-325
[95] DeVivo MT, Edmunds DR, 
Kauffman MJ, Schumaker BA, Binfet 
J, Kreeger TJ, et al. Endemic chronic 
wasting disease causes mule deer 
population decline in Wyoming. PLoS 
One. 2017;12(10):e0186512
[96] Monello RJ, Powers JG, Hobbs 
NT, Spraker TR, O’Rourke KI, Wild 
MA. Efficacy of antemortem rectal 
biopsies to diagnose and estimate 
prevalence of chronic wasting disease 
in free-ranging cow elk (Cervus elaphus 
nelsoni). Journal of Wildlife Diseases. 
2013;49(2):270-278
[97] Keane DP, Barr DJ, Bochsler PN, 
Hall SM, Gidlewski T, O’Rourke KI, 
et al. Chronic wasting disease in a 
33
TSE Monitoring in Wildlife Epidemiology, Transmission, Diagnosis, Genetics and Control
DOI: http://dx.doi.org/10.5772/intechopen.85797
Wisconsin white-tailed deer farm. 
Journal of Veterinary Diagnostic 
Investigation. 2008;20(5):698-703
[98] Clements GM, Hygnstrom SE, 
Gilsdorf JM, Baasch DM, Clements 
MJ, Vercauteren KC. Movements of 
white-tailed deer in Riparian Habitat: 
Implications for infectious diseases. 
Journal of Wildlife Management. 
2011;75(6):1436-1442
[99] Houston F, Andréoletti O. Chapter 
25—The zoonotic potential of animal 
prion diseases. In: Pocchiari M, Manson 
J, editors. Handbook of Clinical 
Neurology, Human Prion Diseases. Vol. 
153. Amsterdam: Elsevier BV; 2018. pp. 
447-462
[100] Waddell L, Greig J, Mascarenhas M, 
Otten A, Corrin T, Hierlihy K. Current 
evidence on the transmissibility of chronic 
wasting disease prions to humans-A 
systematic review. Transboundary and 
Emerging Diseases. 2018;65(1):37-49
[101] Haley NJ, Siepker C, Walter WD, 
Thomsen BV, Greenlee JJ, Lehmkuhl 
AD, et al. Antemortem detection of 
chronic wasting disease prions in nasal 
brush collections and rectal biopsy 
specimens from white-tailed deer by 
real-time quaking-induced conversion. 
Journal of Clinical Microbiology. 
2016;54(4):1108-1116
[102] Gough KC, Maddison BC. Prion 
transmission: Prion excretion and 
occurrence in the environment. Prion. 
2010;4(4):275-282
[103] Race B, Meade-White K, Race 
R, Chesebro B. Prion infectivity in 
fat of deer with chronic wasting 
disease. Journal of Virology. 
2009;83(18):9608-9610
[104] Saunders SE, Bartelt-Hunt SL, 
Bartz JC. Occurrence, transmission, and 
zoonotic potential of chronic wasting 
disease. Emerging Infectious Diseases. 
2012;18(3):369-376
[105] VerCauteren KC, Pilon JL, Nash 
PB, Phillips GE, Fischer JW. Prion 
remains infectious after passage through 
digestive system of American crows 
(Corvus brachyrhynchos). PLoS One. 
2012;7(10):e45774
[106] Fischer JW, Phillips GE, Nichols 
TA, Vercauteren KC. Could avian 
scavengers translocate infectious prions 
to disease-free areas initiating new 
foci of chronic wasting disease? Prion. 
2013;7(4):263-266
[107] Nichols TA, Fischer JW, Spraker 
TR, Kong Q , VerCauteren KC. CWD 
prions remain infectious after 
passage through the digestive system 
of coyotes (Canis latrans). Prion. 
2015;9(5):367-375
[108] Williams ES, Young S. Spongiform 
encephalopathies in Cervidae. Journal 
of Revue Scientifique et Technique. 
1992;11(2):551-567
[109] Béringue V, Vilotte JL, Laude H. 
Prion agent diversity and species barrier. 
Veterinary Research. 2008;39(4):47
[110] Béringue V, Herzog L, Jaumain 
E, Reine F, Sibille P, Le Dur A, et al. 
Facilitated cross-species transmission 
of prions in extraneural tissue. Science. 
2012;335(6067):472-475
[111] Crowell J, Hughson A, Caughey B, 
Bessen RA. Host determinants of prion 
strain diversity independent of prion 
protein genotype. Journal of Virology. 
2015;89(20):10427-10441
[112] Barria MA, Telling GC, Gambetti 
P, Mastrianni JA, Soto C. Generation of 
a new form of human PrP(Sc) in vitro 
by interspecies transmission from 
cervid prions. The Journal of Biological 
Chemistry. 2011;286(9):7490-7495
[113] Bartz JC, Marsh RF, McKenzie DI, 
Aiken JM. The host range of chronic 
wasting disease is altered on passage in 
ferrets. Virology. 1998;251(2):297-301
Wildlife Population Monitoring
34
[114] Harrathi C, Fernández-Borges 
N, Eraña H, Elezgarai SR, Venegas 
V, Charco JM, et al. Insights into 
the bidirectional properties of the 
sheep–deer prion transmission barrier. 
Molecular Neurobiology. 2018. DOI: 
10.1007/s12035-018-1443-8
[115] Browning SR, Mason GL, Seward 
T, Green M, Eliason GA, Mathiason 
C, et al. Transmission of prions from 
mule deer and elk with chronic wasting 
disease to transgenic mice expressing 
cervid PrP. Journal of Virology. 
2004;78(23):13345-13350
[116] Kong Q , Huang S, Zou W, Vanegas 
D, Wang M, Wu D, et al. Chronic 
wasting disease of elk: Transmissibility 
to humans examined by transgenic 
mouse models. The Journal of 
Neuroscience. 2005;25(35):7944-7949
[117] LaFauci G, Carp RI, Meeker HC, 
Ye X, Kim JI, Natelli M, et al. Passage 
of chronic wasting disease prion into 
transgenic mice expressing Rocky 
Mountain elk (Cervus elaphus nelsoni) 
PrPC. The Journal of General Virology. 
2006;87(Pt 12):3773-3780
[118] Tamgüney G, Giles K, Bouzamondo-
Bernstein E, Bosque PJ, Miller MW, Safar 
J, et al. Transmission of elk and deer 
prions to transgenic mice. Journal of 
Virology. 2006;80(18):9104-9114
[119] Madsen-Bouterse SA, Schneider 
DA, Zhuang D, Dassanayake RP, 
Balachandran A, Mitchell GB, et al. 
Primary transmission of chronic 
wasting disease versus scrapie prions 
from small ruminants to transgenic 
mice expressing ovine or cervid 
prion protein. The Journal of General 
Virology. 2016;97(9):2451-2460
[120] Scott M, Foster D, Mirenda C, 
Serban D, Coufal F, Wälchli M, et al. 
Transgenic mice expressing hamster 
prion protein produce species-specific 
scrapie infectivity and amyloid plaques. 
Cell. 1989;59(5):847-857
[121] Scott M, Groth D, Foster D, 
Torchia M, Yang S-L, DeArmond 
SJ, et al. Propagation of prions with 
artificial properties in transgenic mice 
expressing chimeric PrP genes. Cell. 
1993;73(5):979-988
[122] Hara H, Hanada K, Ki H. Species-
barrier phenomenon in prion 
transmissibility from a viewpoint 
of protein science. The Journal of 
Biochemistry. 2013;153(2):139-145
[123] Vanik DL, Surewicz KA, Surewicz 
WK. Molecular basis of barriers 
for interspecies transmissibility of 
mammalian prions. Molecular Cell. 
2004;14(1):139-145
[124] Sandberg MK, Al-Doujaily H, 
Sigurdson CJ, Glatzel M, O'Malley C,  
Powell C, et al. Chronic wasting 
disease prions are not transmissible to 
transgenic mice overexpressing human 
prion protein. The Journal of General 
Virology. 2010;91(Pt 10):2651-2657
[125] Ironside JW, Head MW. Exploring 
the zoonotic potential of animal prion 
diseases AU—Barria, Marcelo A. Prion. 
2014;8(1):85-91
[126] Lockey R, Beck KE, Simmons 
MM, Sallis RE, Spiropoulos J. Ovine PrP 
genotype is linked with lesion profile 
and immunohistochemistry patterns 
after primary transmission of classical 
scrapie to wild-type mice. Journal of 
Neuropathology and Experimental 
Neurology. 2010;69(5):483-497
[127] Beck KE, Sallis RE, Lockey R, 
Vickery CM, Béringue V, Laude H, 
et al. Use of murine bioassay to resolve 
ovine transmissible spongiform 
encephalopathy cases showing a bovine 
spongiform encephalopathy molecular 
profile. Brain pathology (Zurich, 
Switzerland). 2012;22(3):265-279
[128] Beck KE, Vickery CM, Lockey R, 
Holder T, Thorne L, Terry LA, et al. The 
interpretation of disease phenotypes 
35
TSE Monitoring in Wildlife Epidemiology, Transmission, Diagnosis, Genetics and Control
DOI: http://dx.doi.org/10.5772/intechopen.85797
to identify TSE strains following 
murine bioassay: Characterisation of 
classical scrapie. Veterinary Research. 
2012;43(1):77
[129] Bruce ME. TSE strain variation: 
An investigation into prion disease 
diversity. British Medical Bulletin. 
2003;66(1):99-108
[130] Bruce ME, Boyle A, Cousens S, 
McConnell I, Foster J, Goldmann W, 
et al. Strain characterization of natural 
sheep scrapie and comparison with 
BSE. The Journal of General Virology. 
2002;83:695-704
[131] Bencsik A, Vulin J, Lakhdar 
L, Baron T, Spiropoulos J, Beck 
KE. Selection of distinct strain 
phenotypes in mice infected by ovine 
natural scrapie isolates similar to 
CH1641 experimental scrapie. Journal 
of Neuropathology and Experimental 
Neurology. 2012;71(2):140-147
[132] Cordier C, Bencsik A, Philippe 
S, B_etemps D, Ronzon F, Calavas D, 
et al. Transmission and characterization 
of bovine spongiform encephalopathy 
sources in two ovine transgenic mouse 
lines (TgOvPrP4 and TgOvPrP59). 
Journal of General Virology. 
2006;87:3763-3771
[133] Crozet C, Flamant F, Bencsik A, 
Aubert D, Samarut J, Baron T. Efficient 
transmission of two different sheep 
scrapie isolates in transgenic mice 
expressing the ovine PrP gene. Journal 
of Virology. 2001;75(11):5328-5334
[134] Vilotte JL, Soulier S, Essalmani R, 
Stinnakre MG, Vaiman D, Lepourry L, 
et al. Markedly increased susceptibility 
to natural sheep scrapie of transgenic 
mice expressing ovine prp. Journal of 
Virology. 2001;75(13):5977-5984
[135] Mitchell G, Yogasingam N, Walther 
I, Balachandran A. Experimental 
transmission of chronic wasting disease 
to sheep and goats—P70. Prion 2015 
Poster Abstracts Y1-2015/04/24. Prion. 
2015;9(suppl 1):S11-S99
[136] Luers L, Bannach O, Stöhr J, 
Wördehoff MM, Wolff M, Nagel-
Steger L, et al. Seeded fibrillation as 
molecular basis of the species barrier 
in human prion diseases. PLoS One. 
2013;8(8):e72623-e
[137] Prinz M, Huber G, Macpherson 
AJ, Heppner FL, Glatzel M, Eugster 
HP, et al. Oral prion infection requires 
normal numbers of Peyer's patches 
but not of enteric lymphocytes. 
The American Journal of Pathology. 
2003;162(4):1103-1111
[138] Glaysher BR, Mabbott NA. Role of 
the GALT in scrapie agent neuroinvasion 
from the intestine. Journal of 
Immunology. 2007;178(6):3757-3766
[139] Donaldson DS, Else KJ, Mabbott 
NA. The Gut-associated lymphoid 
tissues in the small intestine, not the 
large intestine, play a major role in oral 
prion disease pathogenesis. Journal of 
Virology. 2015;89(18):9532-9547
[140] Donaldson DS, Mabbott 
NA. The influence of the commensal 
and pathogenic gut microbiota 
on prion disease pathogenesis. 
The Journal of General Virology. 
2016;97(8):1725-1738
[141] Mabbott NA, Donaldson DS, 
Ohno H, Williams IR, Mahajan 
A. Microfold (M) cells: Important 
immunosurveillance posts in the 
intestinal epithelium. Mucosal 
Immunology. 2013;6(4):666-677
[142] Wyckoff AC, Kane S, Lockwood 
K, Seligman J, Michel B, Hill D, 
et al. Clay components in soil 
dictate environmental stability and 
bioavailability of cervid prions in mice. 
Frontiers in Microbiology. 2016;7:1885
[143] Kujala P, Raymond CR, Romeijn 
M, Godsave SF, van Kasteren SI, 
Wildlife Population Monitoring
36
Wille H, et al. Prion uptake in the gut: 
Identification of the first uptake and 
replication sites. PLoS Pathogens. 
2011;7(12):e1002449
[144] Mabbott NA, Alibhai JD, Manson 
J. The role of the immune system in 
prion infection. Handbook of Clinical 
Neurology. 2018;153:85-107
[145] Kitamoto T, Muramoto T, Mohri 
S, Doh-Ura K, Tateishi J. Abnormal 
isoform of prion protein accumulates 
in follicular dendritic cells in mice with 
Creutzfeldt-Jakob disease. Journal of 
Virology. 1991;65(11):6292-6295
[146] McBride PA, Eikelenboom P, Kraal 
G, Fraser H, Bruce ME. PrP protein 
is associated with follicular dendritic 
cells of spleens and lymph nodes 
in uninfected and scrapie-infected 
mice. The Journal of Pathology. 
1992;168(4):413-418
[147] Hilton DA, Fathers E, Edwards 
P, Ironside JW, Zajicek J. Prion 
immunoreactivity in appendix 
before clinical onset of variant 
Creutzfeldt-Jakob disease. Lancet. 
1998;352(9129):703-704
[148] Sigurdson CJ, Williams ES, Miller 
MW, Spraker TR, O’Rourke KI, Hoover 
EA. Oral transmission and early 
lymphoid tropism of chronic wasting 
disease PrPres in mule deer fawns 
(Odocoileus hemionus). The Journal of 
General Virology. 1999;80 
(Pt 10):2757-2764
[149] Andreoletti O, Berthon P, Marc D, 
Sarradin P, Grosclaude J, van Keulen L, 
et al. Early accumulation of PrP(Sc) in 
gut-associated lymphoid and nervous 
tissues of susceptible sheep from a 
Romanov flock with natural scrapie. 
The Journal of General Virology. 
2000;81(Pt 12):3115-3126
[150] Mitchell DA, Kirby L, Paulin SM, 
Villiers CL, Sim RB. Prion protein 
activates and fixes complement 
directly via the classical pathway: 
Implications for the mechanism of 
scrapie agent propagation in lymphoid 
tissue. Molecular Immunology. 
2007;44(11):2997-3004
[151] Sim RB, Kishore U, Villiers CL, 
Marche PN, Mitchell DA. C1q binding 
and complement activation by prions 
and amyloids. Immunobiology. 
2007;212(4-5):355-362
[152] Klein MA, Kaeser PS, Schwarz P, 
Weyd H, Xenarios I, Zinkernagel RM, 
et al. Complement facilitates early 
prion pathogenesis. Nature Medicine. 
2001;7(4):488-492
[153] Mabbott NA, Bruce ME, Botto 
M, Walport MJ, Pepys MB. Temporary 
depletion of complement component 
C3 or genetic deficiency of C1q 
significantly delays onset of scrapie. 
Nature Medicine. 2001;7(4):485-487
[154] Zabel M, Heikenwälder M, Prinz 
M, Arrighi I, Schwarz P, Kranich J, et al. 
Stromal complement receptor CD21/35 
facilitates lymphoid prion colonization 
and pathogenesis. The Journal of 
Immunology. 2007;179(9):6144-6152
[155] Michel B, Ferguson A, Johnson T, 
Bender H, Meyerett-Reid C, Pulford B, 
et al. Genetic depletion of complement 
receptors CD21/35 prevents terminal 
prion disease in a mouse model of 
chronic wasting disease. Journal of 
Immunology (Baltimore, MD: 1950). 
2012;189(9):4520-4527
[156] Michel B, Ferguson A, Johnson 
T, Bender H, Meyerett-Reid C, 
Wyckoff AC, et al. Complement 
protein C3 exacerbates prion disease 
in a mouse model of chronic wasting 
disease. International Immunology. 
2013;25(12):697-702
[157] Shortman K, Liu YJ. Mouse 
and human dendritic cell subtypes. 
Nature Reviews. Immunology. 
2002;2(3):151-161
37
TSE Monitoring in Wildlife Epidemiology, Transmission, Diagnosis, Genetics and Control
DOI: http://dx.doi.org/10.5772/intechopen.85797
[158] Mabbott NA, Kenneth Baillie J, 
Kobayashi A, Donaldson DS, Ohmori 
H, Yoon S-O, et al. Expression of 
mesenchyme-specific gene signatures by 
follicular dendritic cells: Insights from 
the meta-analysis of microarray data 
from multiple mouse cell populations. 
Immunology. 2011;133(4):482-498
[159] McGovern G, Mabbott N, Jeffrey 
M. Scrapie affects the maturation cycle 
and immune complex trapping by 
follicular dendritic cells in mice. PLoS 
One. 2009;4(12):e8186-e
[160] O'Connor T, Frei N, Sponarova 
J, Schwarz P, Heikenwalder M, 
Aguzzi A. Lymphotoxin, but not 
TNF, is required for prion invasion 
of lymph nodes. PLoS Pathogens. 
2012;8(8):e1002867
[161] Fraser H, Brown KL, Stewart K, 
McConnell I, McBride P, Williams 
A. Replication of scrapie in spleens of 
SCID mice follows reconstitution with 
wild-type mouse bone marrow. The 
Journal of General Virology. 1996;77 
(Pt 8):1935-1940
[162] Klein MA, Frigg R, Flechsig E, 
Raeber AJ, Kalinke U, Bluethmann 
H, et al. A crucial role for B cells 
in neuroinvasive scrapie. Nature. 
1997;390(6661):687-690
[163] Mohan J, Brown KL, Farquhar 
CF, Bruce ME, Mabbott NA. Scrapie 
transmission following exposure 
through the skin is dependent on 
follicular dendritic cells in lymphoid 
tissues. Journal of Dermatological 
Science. 2004;35(2):101-111
[164] McFarlin DE, Raff MC, 
Simpson E, Nehlsen SH. Scrapie in 
immunologically deficient mice. Nature. 
1971;233(5318):336
[165] Fraser H, Dickinson AG. Studies 
of the lymphoreticular system 
in the pathogenesis of scrapie: 
The role of spleen and thymus. 
Journal of Comparative Pathology. 
1978;88(4):563-573
[166] Raeber AJ, Sailer A, Hegyi I, 
Klein MA, Rülicke T, Fischer M, et al. 
Ectopic expression of prion protein 
(PrP) in T lymphocytes or hepatocytes 
of PrP knockout mice is insufficient to 
sustain prion replication. Proceedings 
of the National Academy of Sciences. 
1999;96(7):3987
[167] Montrasio F, Cozzio A, Flechsig 
E, Rossi D, Klein MA, Rülicke T, et al. 
B lymphocyte-restricted expression 
of prion protein does not enable prion 
replication in prion protein knockout 
mice. Proceedings of the National 
Academy of Sciences. 2001;98(7):4034
[168] Mackay F, Browning JL. Turning 
off follicular dendritic cells. Nature. 
1998;395(6697):26-27
[169] Schmidt TH, Bannard O, Gray 
EE, Cyster JG. CXCR4 promotes B 
cell egress from Peyer's patches. The 
Journal of Experimental Medicine. 
2013;210(6):1099-1107
[170] Suzuki K, Grigorova I, Phan 
TG, Kelly LM, Cyster JG. Visualizing 
B cell capture of cognate antigen 
from follicular dendritic cells. The 
Journal of Experimental Medicine. 
2009;206(7):1485-1493
[171] Mok SW, Proia RL, Brinkmann 
V, Mabbott NA. B cell-specific S1PR1 
deficiency blocks prion dissemination 
between secondary lymphoid 
organs. Journal of Immunology. 
2012;188(10):5032-5040
[172] Edwards JC, Moore SJ, Hawthorn 
JA, Neale MH, Terry LA. PrP(Sc) is 
associated with B cells in the blood 
of scrapie-infected sheep. Virology. 
2010;405(1):110-119
[173] Mathiason CK, Hayes-Klug J, Hays 
SA, Powers J, Osborn DA, Dahmes SJ, 
et al. B cells and platelets harbor prion 
Wildlife Population Monitoring
38
infectivity in the blood of deer infected 
with chronic wasting disease. Journal of 
Virology. 2010;84(10):5097-5107
[174] Horiuchi M, Furuoka H, Kitamura 
N, Shinagaw M. Alymphoplasia 
mice are resistant to prion infection 
via oral route. The Japanese 
Journal of Veterinary Research. 
2006;53(3-4):149-157
[175] van Keulen LJ, Bossers A, van 
Zijderveld F. TSE pathogenesis in 
cattle and sheep. Veterinary Research. 
2008;39(4):24
[176] van Keulen LJ, Schreuder BE, 
Vromans ME, Langeveld JP, Smits 
MA. Pathogenesis of natural scrapie 
in sheep. Archives of Virology. 
Supplementum. 2000;(16):57-71
[177] van Keulen LJ, Vromans ME, 
van Zijderveld FG. Early and late 
pathogenesis of natural scrapie infection 
in sheep. APMIS. 2002;110(1):23-32
[178] Tabouret G, Lacroux C, Lugan S, 
Costes P, Corbiere F, Weisbecker JL, 
et al. Relevance of oral experimental 
challenge with classical scrapie in 
sheep. The Journal of General Virology. 
2010;91(Pt 8):2139-2144
[179] Espenes A, Press C, Landsverk T, 
Tranulis M, Aleksandersen M, Gunnes 
G, et al. Detection of PrP(Sc) in Rectal 
Biopsy and Necropsy Samples from 
Sheep with Experimental Scrapie. 
Journal of Comparative Pathology. 
2006;134(2-3):115-125
[180] Gonzalez L, Dagleish MP, 
Bellworthy SJ, Siso S, Stack MJ, 
Chaplin MJ, et al. Postmortem 
diagnosis of preclinical and clinical 
scrapie in sheep by the detection of 
disease-associated PrP in their rectal 
mucosa. The Veterinary Record. 
2006;158(10):325-331
[181] Gonzalez L, Martin S, Siso S, 
Konold T, Ortiz-Pelaez A, Phelan L, 
et al. High prevalence of scrapie in a 
dairy goat herd: Tissue distribution of 
disease-associated PrP and effect of 
PRNP genotype and age. Veterinary 
Research. 2009;40(6):65
[182] Spraker TR, Gidlewski TL, 
Balachandran A, VerCauteren KC, 
Creekmore L, Munger RD. Detection 
of PrP(CWD) in postmortem rectal 
lymphoid tissues in Rocky Mountain 
elk (Cervus elaphus nelsoni) infected 
with chronic wasting disease. Journal 
of Veterinary Diagnostic Investigation. 
2006;18(6):553-557
[183] Wolfe LL, Spraker TR, Gonzalez L, 
Dagleish MP, Sirochman TM, Brown JC, 
et al. PrPCWD in rectal lymphoid tissue 
of deer (Odocoileus spp.). The Journal 
of General Virology. 2007;88 
(Pt 7):2078-2082
[184] Thomsen BV, Schneider DA, 
O’Rourke KI, Gidlewski T, McLane J, 
Allen RW, et al. Diagnostic accuracy of 
rectal mucosa biopsy testing for chronic 
wasting disease within white-tailed 
deer (Odocoileus virginianus) herds in 
North America: Effects of age, sex, 
polymorphism at PRNP codon 96, 
and disease progression. Journal of 
Veterinary Diagnostic Investigation. 
2012;24(5):878-887
[185] McCulloch L, Brown KL, Bradford 
BM, Hopkins J, Bailey M, Rajewsky K, 
et al. Follicular dendritic cell-specific 
prion protein (PrP) expression alone 
is sufficient to sustain prion infection 
in the spleen. PLoS Pathogens. 
2011;7(12):e1002402
[186] Krautler NJ, Kana V, Kranich 
J, Tian Y, Perera D, Lemm D, et al. 
Follicular dendritic cells emerge from 
ubiquitous perivascular precursors. Cell. 
2012;150(1):194-206
[187] Liu LM, MacPherson GG. Antigen 
acquisition by dendritic cells: 
Intestinal dendritic cells acquire 
antigen administered orally and 
39
TSE Monitoring in Wildlife Epidemiology, Transmission, Diagnosis, Genetics and Control
DOI: http://dx.doi.org/10.5772/intechopen.85797
can prime naive T cells in vivo. The 
Journal of experimental medicine. 
1993;177(5):1299-1307
[188] Banchereau J, Briere F, Caux C, 
Davoust J, Lebecque S, Liu YJ, et al. 
Immunobiology of dendritic cells. 
Annual Review of Immunology. 
2000;18:767-811
[189] Cerovic V, Houston SA, Westlund J, 
Utriainen L, Davison ES, Scott CL, et al. 
Lymph-borne CD8alpha+ dendritic 
cells are uniquely able to cross-prime 
CD8+ T cells with antigen acquired 
from intestinal epithelial cells. Mucosal 
Immunology. 2015;8(1):38-48
[190] Wykes M, Pombo A, Jenkins C, 
MacPherson GG. Dendritic cells interact 
directly with naive B lymphocytes 
to transfer antigen and initiate class 
switching in a primary T-dependent 
response. Journal of Immunology. 
1998;161(3):1313-1319
[191] Macpherson AJ, Uhr T. Induction 
of protective IgA by intestinal dendritic 
cells carrying commensal bacteria. 
Science. 2004;303(5664):1662-1665
[192] Saeki H, Wu MT, Olasz E, Hwang 
ST. A migratory population of skin-
derived dendritic cells expresses 
CXCR5, responds to B lymphocyte 
chemoattractant in vitro, and 
co-localizes to B cell zones in lymph 
nodes in vivo. European Journal of 
Immunology. 2000;30(10):2808-2814
[193] Leon B, Ballesteros-Tato A, 
Browning JL, Dunn R, Randall 
TD, Lund FE. Regulation of T(H)2 
development by CXCR5+ dendritic 
cells and lymphotoxin-expressing 
B cells. Nature Immunology. 
2012;13(7):681-690
[194] Flores-Langarica A, Sebti Y, 
Mitchell D, Sim R, Macpherson 
G. Scrapie Pathogenesis: The Role of 
Complement C1q in Scrapie Agent 
Uptake by Conventional Dendritic 
Cells. The Journal of Immunology. 
2009;182(3):1305-1313
[195] Gunn MD, Ngo VN, Ansel KM, 
Ekland EH, Cyster JG, Williams LT. A 
B-cell-homing chemokine made in 
lymphoid follicles activates Burkitt's 
lymphoma receptor-1. Nature. 
1998;391(6669):799-803
[196] Ansel KM, Ngo VN, Hyman PL, 
Luther SA, Forster R, Sedgwick JD, et al. 
A chemokine-driven positive feedback 
loop organizes lymphoid follicles. 
Nature. 2000;406(6793):309-314
[197] Yu P, Wang Y, Chin RK, Martinez-
Pomares L, Gordon S, Kosco-Vibois 
MH, et al. B cells control the migration 
of a subset of dendritic cells into 
B cell follicles via CXC chemokine 
ligand 13 in a lymphotoxin-dependent 
fashion. Journal of Immunology. 
2002;168(10):5117-5123
[198] Bradford BM, Reizis B, Mabbott 
NA. Oral prion disease pathogenesis 
is impeded in the specific absence of 
CXCR5-expressing dendritic cells. 
Journal of Virology. 2017;91(10)
[199] Raymond CR, Aucouturier 
P, Mabbott NA. In vivo depletion 
of CD11c+ cells impairs scrapie 
agent neuroinvasion from the 
intestine. Journal of Immunology. 
2007;179(11):7758-7766
[200] Sethi S, Kerksiek KM, Brocker 
T, Kretzschmar H. Role of the CD8+ 
dendritic cell subset in transmission 
of prions. Journal of Virology. 
2007;81(9):4877-4880
[201] Cordier-Dirikoc S, Chabry 
J. Temporary depletion of CD11c+ 
dendritic cells delays lymphoinvasion 
after intraperitonal scrapie 
infection. Journal of Virology. 
2008;82(17):8933-8936
[202] Wathne GJ, Kissenpfennig A, 
Malissen B, Zurzolo C, Mabbott NA. 
Wildlife Population Monitoring
40
Determining the role of mononuclear 
phagocytes in prion neuroinvasion from 
the skin. Journal of Leukocyte Biology. 
2012;91(5):817-828
[203] Berney C, Herren S, Power CA, 
Gordon S, Martinez-Pomares L, 
Kosco-Vilbois MH. A member of the 
dendritic cell family that enters B 
cell follicles and stimulates primary 
antibody responses identified by a 
mannose receptor fusion protein. The 
Journal of Experimental Medicine. 
1999;190(6):851-860
[204] Carp RI, Callahan SM. In vitro 
interaction of scrapie agent and mouse 
peritoneal macrophages. Intervirology. 
1981;16(1):8-13
[205] Carp RI, Callahan SM. Effect of 
mouse peritoneal macrophages on 
scrapie infectivity during extended 
in vitro incubation. Intervirology. 
1982;17(4):201-207
[206] Beringue V, Demoy M, Lasmezas 
CI, Gouritin B, Weingarten C, Deslys 
JP, et al. Role of spleen macrophages in 
the clearance of scrapie agent early in 
pathogenesis. The Journal of Pathology. 
2000;190(4):495-502
[207] Maignien T, Shakweh M, Calvo 
P, Marce D, Sales N, Fattal E, et al. 
Role of gut macrophages in mice 
orally contaminated with scrapie 
or BSE. International Journal of 
Pharmaceutics. 2005;298(2):293-304
[208] Beekes M, Baldauf E, Diringer 
H. Sequential appearance and 
accumulation of pathognomonic 
markers in the central nervous system 
of hamsters orally infected with scrapie. 
The Journal of General Virology. 
1996;77(Pt 8):1925-1934
[209] Beekes M, McBride PA, Baldauf 
E. Cerebral targeting indicates vagal 
spread of infection in hamsters fed 
with scrapie. The Journal of General 
Virology. 1998;79(Pt 3):601-607
[210] Baldauf E, Beekes M, Diringer 
H. Evidence for an alternative direct 
route of access for the scrapie agent to 
the brain bypassing the spinal cord. The 
Journal of General Virology. 1997;78 
(Pt 5):1187-1197
[211] McBride PA, Beekes M. 
Pathological PrP is abundant in 
sympathetic and sensory ganglia of 
hamsters fed with scrapie. Neuroscience 
Letters. 1999;265(2):135-138
[212] McBride PA, Schulz-Schaeffer WJ, 
Donaldson M, Bruce M, Diringer H, 
Kretzschmar HA, et al. Early spread of 
scrapie from the gastrointestinal tract 
to the central nervous system involves 
autonomic fibers of the splanchnic 
and vagus nerves. Journal of Virology. 
2001;75(19):9320-9327
[213] Sowinski S, Jolly C, Berninghausen 
O, Purbhoo MA, Chauveau A, Kohler K, 
et al. Membrane nanotubes physically 
connect T cells over long distances 
presenting a novel route for HIV-1 
transmission. Nature Cell Biology. 
2008;10(2):211-219
[214] Aucouturier P, Geissmann F, 
Damotte D, Saborio GP, Meeker HC, 
Kascsak R, et al. Infected splenic 
dendritic cells are sufficient for 
prion transmission to the CNS in 
mouse scrapie. The Journal of clinical 
investigation. 2001;108(5):703-708
[215] Gousset K, Schiff E, Langevin C, 
Marijanovic Z, Caputo A, Browman DT, 
et al. Prions hijack tunnelling nanotubes 
for intercellular spread. Nature Cell 
Biology. 2009;11(3):328-336
[216] Langevin C, Gousset K, Costanzo 
M, Richard-Le Goff O, Zurzolo 
C. Characterization of the role of 
dendritic cells in prion transfer to 
primary neurons. The Biochemical 
Journal. 2010;431(2):189-198
[217] Tanaka Y, Sadaike T, Inoshima Y, 
Ishiguro N. Characterization of PrP(Sc) 
41
TSE Monitoring in Wildlife Epidemiology, Transmission, Diagnosis, Genetics and Control
DOI: http://dx.doi.org/10.5772/intechopen.85797
transmission from immune cells to 
neuronal cells. Cellular Immunology. 
2012;279(2):145-150
[218] Zhu S, Victoria GS, Marzo L, 
Ghosh R, Zurzolo C. Prion aggregates 
transfer through tunneling nanotubes 
in endocytic vesicles. Prion. 
2015;9(2):125-135
[219] Fevrier B, Vilette D, Archer F, 
Loew D, Faigle W, Vidal M, et al. 
Cells release prions in association 
with exosomes. Proceedings of 
the National Academy of Sciences 
of the United States of America. 
2004;101(26):9683-9688
[220] Castro-Seoane R, Hummerich 
H, Sweeting T, Tattum MH, Linehan 
JM, Fernandez de Marco M, et al. 
Plasmacytoid dendritic cells sequester 
high prion titres at early stages of 
prion infection. PLoS Pathogens. 
2012;8(2):e1002538
[221] Jeffrey M, Halliday WG, Bell J, 
Johnston AR, MacLeod NK, Ingham 
C, et al. Synapse loss associated with 
abnormal PrP precedes neuronal 
degeneration in the scrapie-infected 
murine hippocampus. Neuropathology 
and Applied Neurobiology. 
2000;26(1):41-54
[222] Jamieson E, Jeffrey M, Ironside 
JW, Fraser JR. Apoptosis and 
dendritic dysfunction precede prion 
protein accumulation in 87V scrapie. 
NeuroReport. 2001;12(10):2147-2153
[223] Cunningham C, Deacon R, 
Wells H, Boche D, Waters S, Diniz CP, 
et al. Synaptic changes characterize 
early behavioural signs in the ME7 
model of murine prion disease. The 
European Journal of Neuroscience. 
2003;17(10):2147-2155
[224] Siskova Z, Reynolds RA, O'Connor 
V, Perry VH. Brain region specific 
pre-synaptic and post-synaptic 
degeneration are early components of 
neuropathology in prion disease. PLoS 
One. 2013;8(1):e55004
[225] Betmouni S, Perry VH, Gordon 
JL. Evidence for an early inflammatory 
response in the central nervous system 
of mice with scrapie. Neuroscience. 
1996;74(1):1-5
[226] Vincenti JE, Murphy L, Grabert K, 
McColl BW, Cancellotti E, Freeman TC, 
et al. Defining the microglia response 
during the time course of chronic 
neurodegeneration. Journal of Virology. 
2015;90(6):3003-3017
[227] Falsig J, Julius C, Margalith 
I, Schwarz P, Heppner FL, Aguzzi 
A. A versatile prion replication assay 
in organotypic brain slices. Nature 
Neuroscience. 2008;11(1):109-117
[228] Zhu C, Herrmann US, Falsig J, 
Abakumova I, Nuvolone M, Schwarz 
P, et al. A neuroprotective role for 
microglia in prion diseases. The 
Journal of Experimental Medicine. 
2016;213(6):1047-1059
[229] Minghetti L, Greco A, Cardone 
F, Puopolo M, Ladogana A, Almonti 
S, et al. Increased brain synthesis of 
prostaglandin E2 and F2-isoprostane in 
human and experimental transmissible 
spongiform encephalopathies. Journal 
of Neuropathology and Experimental 
Neurology. 2000;59(10):866-871
[230] Boche D, Cunningham C, Gauldie 
J, Perry VH. Transforming growth 
factor-beta 1-mediated neuroprotection 
against excitotoxic injury in vivo. 
Journal of Cerebral Blood Flow and 
Metabolism. 2003;23(10):1174-1182
[231] Thackray AM, McKenzie AN, Klein 
MA, Lauder A, Bujdoso R. Accelerated 
prion disease in the absence of 
interleukin-10. Journal of Virology. 
2004;78(24):13697-13707
[232] Tamguney G, Giles K, Glidden 
DV, Lessard P, Wille H, Tremblay P, 
Wildlife Population Monitoring
42
et al. Genes contributing to prion 
pathogenesis. The Journal of General 
Virology. 2008;89(Pt 7):1777-1788
[233] Gomez-Nicola D, Fransen NL, 
Suzzi S, Perry VH. Regulation of 
microglial proliferation during chronic 
neurodegeneration. The Journal of 
Neuroscience. 2013;33(6):2481-2493
[234] Alibhai J, Blanco RA, Barria MA, 
Piccardo P, Caughey B, Perry VH, et al. 
Distribution of misfolded prion protein 
seeding activity alone does not predict 
regions of neurodegeneration. PLoS 
Biology. 2016;14(11):e1002579-e
[235] Gilch S. Overview of Chronic 
Wasting Disease. https://www.
msdvetmanual.com/nervous-system/
chronic-wasting-disease/overview-of-
chronic-wasting-disease (accessed 25 
April 2019)
[236] The Center for Food Security 
& Public Health. Chronic Wasting 
Disease. http://www.cfsph.iastate.edu/
Factsheets/pdfs/chronic_wasting_
disease.pdf (accessed 25 April 2019)
[237] Spraker TR, Miller MW, Williams 
ES, Getzy DM, Adrian WJ, Schoonveld 
GG, et al. Spongiform encephalopathy 
in free-ranging mule deer (Odocoileus 
hemionus), white-tailed deer (Odocoileus 
virginianus) and rocky mountain elk 
(Cervus elaphus nelsoni) in northcentral 
Colorado. Journal of Wildlife Diseases. 
1997;33(1):1-6
[238] Vaccines OMoDTa, Animals fT. 
2018. Available from: http://www.oie.
int/standard-setting/terrestrial-manual/
access-online/
[239] Authority EFS. The European 
Union summary report on surveillance 
for the presence of transmissible 
spongiform encephalopathies (TSEs) 
in 2017. EFSA Journal (published by 
John Wiley and Sons Ltd on behalf 
of European Food Safety Authority). 
2018
[240] Andreoletti O, Budka H, Buncic 
S, Colin P, Collins JD, De Koeijer A, 
et al. Protocol for the evaluation of 
new rapid BSE post mortem tests. 
Opinion of the scientific panel on 
biological hazards. The European 
Food Safety Authority (EFSA) Journal. 
2007;508:1-20
[241] Andreoletti O, Budka H, Buncic S, 
Colin P, Collins JD, De Koeijer A, et al. 
Protocol for the evaluation of rapid post 
mortem tests TSE in small ruminants. 
Opinion of the scientific panel on 
biological hazards. The European 
Food Safety Authority (EFSA) Journal. 
2007;509:1-31
[242] Sigurdson CJ, Aguzzi A. Chronic 
wasting disease. Biochimica et 
Biophysica Acta. 2007;1772(6):610-618
[243] Xie Z, O’Rourke KI, Dong Z, 
Jenny AL, Langenberg JA, Belay 
ED, et al. Chronic wasting disease 
of elk and deer and Creutzfeldt-
Jakob disease: Comparative analysis 
of the scrapie prion protein. The 
Journal of Biological Chemistry. 
2006;281(7):4199-4206
[244] O’Rourke KI, Zhuang D, Lyda 
A, Gomez G, Williams ES, Tuo W, 
et al. Abundant PrP(CWD) in tonsil 
from mule deer with preclinical 
chronic wasting disease. Journal of 
Veterinary Diagnostic Investigation. 
2003;15(4):320-323
[245] Andréoletti O, Orge L, Benestad 
SL, Beringue V, Litaise C, Simon S, 
et al. Atypical/Nor98 scrapie infectivity 
in sheep peripheral tissues. PLoS 
Pathogens. 2011;7(2):e1001285
[246] Jacobs JG, Langeveld JPM, 
Biacabe A-G, Acutis P-L, Polak MP, 
Gavier-Widen D, et al. Molecular 
discrimination of atypical bovine 
spongiform encephalopathy strains 
from a geographical region spanning a 
wide area in Europe. Journal of Clinical 
Microbiology. 2007;45(6):1821-1829
43
TSE Monitoring in Wildlife Epidemiology, Transmission, Diagnosis, Genetics and Control
DOI: http://dx.doi.org/10.5772/intechopen.85797
[247] (TSE) EEURLEf. TSE strain 
characterisation in small ruminants. 
A technical handbook for national 
reference laboratories in the EU. 2016. 
Available from: https://science.vla.gov.
uk/tse-lab-net/documents/tse-oie-rl-
handbook.pdf
[248] Daus ML, Breyer J, Wagenfuehr 
K, Wemheuer WM, Thomzig A, 
Schulz-Schaeffer WJ, et al. Presence 
and seeding activity of pathological 
prion protein (PrP(TSE)) in skeletal 
muscles of white-tailed deer infected 
with chronic wasting disease. PLoS One. 
2011;6(4):e18345-e
[249] Pulford B, Spraker TR, Wyckoff 
AC, Meyerett C, Bender H, Ferguson A, 
et al. Detection of PrPCWD In Feces From 
Naturally Exposed Rocky Mountain Elk 
(Cervus elaphus nelsoni) Using Protein 
Misfolding Cyclic Amplification. Journal 
of Wildlife Diseases. 2012;48:425-434
[250] Atarashi R, Wilham JM, 
Christensen L, Hughson AG, Moore 
RA, Johnson LM, et al. Simplified 
ultrasensitive prion detection by 
recombinant PrP conversion with 
shaking. Nature Methods. 2008;5:211
[251] Haley NJ, Richt JA. Evolution of 
diagnostic tests for chronic wasting 
disease, a naturally occurring prion 
disease of cervids. Pathogens (Basel, 
Switzerland). 2017;6(3):35
[252] Ricci A, Allende A, Bolton D, 
Chemaly M, Davies R, Fernández 
Escámez PS, et al. Chronic wasting 
disease (CWD) in cervids. EFSA 
Panel on Biological Hazards. 
2017;15(1):e04667
[253] Samuel MD, Joly DO, Wild MA, 
Wright SD, Otis DL, Werge RW, et al. 
Surveillance Strategies for Detecting 
Chronic Wasting Disease in Free-
ranging Deer and Elk: Results of a 
CWD Surveillance Workshop. Madison, 
WI: U.S. Geological Survey, National 
Wildlife Health Center; 2003. 43 p
[254] Uehlinger FD, Johnston AC, 
Bollinger TK, Waldner CL. Systematic 
review of management strategies 
to control chronic wasting disease 
in wild deer populations in North 
America. BMC Veterinary Research. 
2016;12(1):173
[255] Miller MW, Williams ES, Hobbs 
NT, Wolfe LL. Environmental sources 
of prion transmission in mule deer. 
Emerging Infectious Diseases. 
2004;10(6):1003-1006
[256] Miller MW, Fischer RJ. The First 
Five (or More) Decades of Chronic 
Wasting Disease: Lessons for the 
Five Decades to Come. Transactions 
of the North American Wildlife and 
Natural Resources Conference. 2016;81. 
http://cwd-info.org/wp-content/
uploads/2018/12/81st-NAWNRC-
Transactions_FINAL-CWD-Excerpt.pdf 
(accessed 25 April 2019)
[257] Manjerovic MB, Green ML, 
Mateus-Pinilla N, Novakofski J. The 
importance of localized culling in 
stabilizing chronic wasting disease 
prevalence in white-tailed deer 
populations. Preventive Veterinary 
Medicine. 2014;113(1):139-145
[258] Wolfe LL, Watry MK, Sirochman 
MA, Sirochman TM, Miller 
MW. Evaluation of a test and cull 
strategy for reducing prevalence of 
chronic wasting disease in mule deer 
(Odocoileus hemionus). Journal of 
Wildlife Diseases. 2018;54(3):511-519
